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Molecular ana lysis has revealed that a varie ty of hemoglobin 
molecu les are produced in h umans.  Al l  a re tetramers consisting of 
numerous combinations of seven distinct polypeptide chains,  each 
encoded by a separate gene. 
Feta l hemoglobin is one of these tetram ers that by eight weeks of 
gestation rep /ace the embr yonic hemoglobin forms. Feta l hemoglobin is the 
ma jor hemoglobin in fetal l ife . it 's concentration in b lood decreases a fter 
birth to less than 2 per ce nt of the total hemoglobin by 6 months of age.  
However,  in  some cases fetal hemog lobin pers ist to synthesize i n  adult l ife 
in  abnormal concentrations.  
Our study concerned the fetal hemoglobin expression i n  fou r  
different groups (normal group ,  anemic group , pregnant women group, and 
tha lassemic patients g roup) . 
The resu lts show that fetal hemoglobin i n  the normal group was in 
the normal ranges observed in  other populations ,  there is  no big d i fferences 
be tween males and females , and there was no correlation between fetal 
cel ls level and feta l hemoglobin production .  
In  the anemic g roup there was more fetal hemoglobin present than in 
the normal  g roup and there was no d i fferences between males and 
females . Fetal hemoglobin continue to be expressed in anemic conditions , 
even when due to genetic or environmental factors. 
The fetal  hemoglobin production In pregnant women is 
heterogenous and is sti l l  within the normal fem a le range that was obta ined 
in our study, thi s  indicates that there are no sex l inked genetic factors 
mod u lating  the feta l hemoglobin expression . 
The study shows also, that fetal hemoglobin product ion is 
heterogenous in beta thalassemic patients and there were large variations 
i i  
between the hetero zygous and the homo zygous patients . The large 
d ifferences in expression with in  a homogenous genetic popu lation and, 
sometimes with in  the same fam i ly ,  imposes the problem of feta l hemog lobin 
regu lation and leads us to assume that fetal hemoglobin production is 
u nder at least 2 determinants : genetic ,  nongenetic . 
iii 
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Fetal hemoglobin (Hb F) is the major hemoglobin in fetal life. It's 
concentration in the blood decreases after birth to less than 2 per cent of 
the total hemoglobin by 6 months of age. However , in some cases fetal 
hemoglobin continues to be synthesized in adults life. 
The production of fetal hemoglobin is under the control of many 
factors, the majority classified as genetic and the nongenetic factors . The 
nongenetic factors are physiological factors (i .e. pregnancy, and rapid 
erythroid regeneration) and the acquired disorders. The most known as 
genetic factors are the hemoglobinopathies which can be divided into the 
structural variants (i.e. sickle cell hemoglobin) and disorders of synthesis 
(i.e. (3 tha/assemias). 
Since the expression of fetal hemoglobin appears to be closely 
related to the population and its environment, many reports showed that 
fetal hemoglobin is different from one population to another and in the 
different groups from the same popu!ation. We choose to study the 
expression of fetal hemoglobin in different groups of the UAE population as 
well as some erythrocytic indices. 
Four groups were studied, the normal population (nonanemic) which 
was considered to be the reference group and three other special groups of 
population in whom it is expected to have a differences in fetal hemoglobin 
expression (anemic group, pregnant women group, and a group of �+ 
thalassemic patients of UAE population bearing the same mutation). 
PART I: REVlE\"J OF LITERATURE 
The Hemoglobin Molecule 
Hemoglobin ,  the o xygen transpo rte r  in ver tebrate e ryth ro cytes is a 
tetrame ri c  prote in ,  com posed of two pai rs of subun its (Figure 1 ). Ea ch 
subun it consists of a protoheme to whi ch oxygen binds and a g lobin cha in  
made u p  of amino a cids a rranged i n  a defin ite sequen ce.  The fou r cha ins 
are he ld  together by non co va lent a ttra ction .  A tet rame ri c  hemog lob in 
mole cule has a mole cula r weight o f  about 65,000 Daltons and is rough ly 
sphe ri cal (Asakura and Schwartz,1 990). Although the stru ctu re of the 
heme g roup is common to a l l  hemoglobin subunits (F igure 2), g lobin 
cha ins d i ffe r  in the numbe r and sequen ce o f  amino a cids and a re 
designated by G reek le tters , i n clud ing a. (al pha ), � (bet a), ; (gamma ), 8 
(delta ), r; (epsi lon ), and s (zeta ). The genes for those prote ins a re d iv ided 
into two g roups, t hose for the a.-l i ke g lob ins whi ch have 1 41 amino a cids 
and those fo r the p- like g lobins wh i ch have 1 46 amino a cids .  The 
sequen ce of amino a cids is  d i fferent in ea ch cha in  (Zeringer and 
Harmening, 1 992).  In a hemog lobin mole cu le  ea ch a.-l ike chain is in conta ct 
w ith both fJ-like cha ins.  In  contrast, there a re few inte ra ctions be tween the 
two a-l ike cha ins  or be tween the tv% !3-l i ke cha ins lead i ng to a quaternary 
stru ctu re of hemog lobin .  The stru cture of these chains are summa rized in  
figure 3 (Stryer , 1 988).  
Ontogen y  of Hemoglobin 
The hemoglobin com position of the ery th ro cy te varies depend ing on 
when in gestation or postnata l develo pment it i s  measured . Th is is a res ult 
o f  sequentia l  a ctivation and ina ctivation , or swit ch ing ,  among genes withi n  
the a a n d  non- a g lobin gene cluster (Figure 4) (Steinberg and 
Benz, 1 99 1 ). In adu lt l ife two major hemoglob ins are p resent : Hb A (a2 �2) 
Figure 1: Schematic drawing of human 
hemoglob in .  Hemog lobin i s  composed of two a 
- and two �-chains, with each of the subuni ts  
hav ing a heme prosthet ic group. Oxygen 
combines with the ferrous i ron (from: Asakura 
and Schwartz, 1990, p: 359). 
CHl = CH 
HO·C - CH1 �Hl 
II o 
CH1CH1 - C - OH 
II 
o 
Figure 2: Structure of protoheme (from: 
Asakura and Schwartz, 1990, p: 359). 
3 
Heme 
Figure 3: The hemoglobin molecu le  consists of 
two identical alpha cha ins  each consisting of 
141 amino acid res idues and two identical beta 
chains each cons ist ing of 146 amino acid un its .  
Each cha in  has associated with it an i ron­
conta in ing  heme group (d isc-shaped object) 
(from: Winchester and Mertens, 1983, p: 161). 
HEMOGLOBINS (EMBRYONIC) 
GOWER 1 �2£2 
PORTLAND 1 �2Y2 
GOWER 2 0::2£2 
HEMOGLOBINS (% AT BIRTH) 
HbF 0::2YZ (75) 
HEMOGLOBINS (% IN ADULTS) 
HbA 0::2(J2 (97) 


































y "  
Ii I 
I \ Ii I 
I \ 
I . I 
I \ 
I I I 
I \ 
I i I 
I 
I . I 
I 
I I I 
I 
I \ I 
I 










'\( '1\ � 
, < 
: ', .. / ...... , ....... . 
.... l ... ······· .. · .. ·· .... · .. · .. ·�·�,:: .:.: .... ··· o 
EMBRYO FETUS 
Figure 4: Hemoglobin switching during 
embryonic, feta l, and adult development. The ( 
and E genes are transcribed dur ing embryon ic 
development and soon replaced by the feta l y­
and adult a-g lobin gene. At bi rth, fetal 
hemoglobin forms about 75 per cent and 
hemoglobin A 25 per cent of the total. 
Transcription of the y gene begins to fa l l  prior 
••••• ........ J � . -----
BIRTH 6 MO 1/ ADULT 
TIME 
to Olrth, and by 6 month of age this gene IS 
expressed only at very low levels. expression 
of the 8-g lobin gene beg ins near birth. In adu lts 
hemoglobin A makes up about 97 per cent, 
hemoglobin A2 about 2� per cent, and fetal 
hemoglobin less than 1 per cent of the tota l 
(from: Steinberg, and Benz, 1991, p: 298). 
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and Hb A2 (0:.2 (2). In childhood special hemoglobin has been discovered: 
fetal hemoglobin Hb F (0:2 "(2). 
Three other hemoglobins were discovered in the blood of human 
embryos that differed from adult and fetal hemoglobin. These components 
were called Hb Gower-1 and Hb Gower-2 (Bunn and Forget,1 986). 
Structural analyses have shown Hb Gower-1 to be a tetramer composed 
entirely of embryonic subunits : S21:>2. The 1-; chain is a � like chain and 
encoded by the f1 globin gene complex on chromosome 11. The (, chain 
was found to be an (X like chain and had a strong structural homology to the 
ex chain, it is incoded by s gene located in the 0: like gene family on 
chromosome 16 (Bunn and Forget,1 986). 
A third human embryonic hemoglobin was found and called Hb 
Portand that was shown to be a tetramer composed of two 'Y chains and two 
.::; chains. These three embryonic hemoglobins serve as physiologic oxygen 
carriers (Bunn and Forget,1 986). 
The embryonic hemoglobins are produced in the yolk sac during the 
third though eighth weeks of gestation (Hann et al ., 1991). From about the 
eighth to the r.t./enty-eighth week, the liver becomes the major site of 
erythropoiesis. During the last half of gestation, red cell production 
gradually shifts from the liver and spleen to the bone marrow. When the 
embryo reaches a crown-rump length of 35 mm (about seven weeks 
gestation) Hb F composes about 50 per cent of the total hemoglobin, and 
when the embryo exceeds a crown-rump length of 50 mm (about nine 
weeks gestation) , about 90 per cent of the total is Hb F. There after, the 
embryonic hemoglobins are no longer detectable, and Hb F is the 
predominant hemoglobin in fetal red cells. However, l3-chain synthesis 
begins early in fetal development. At the sixth week of gestation, Hb A 
composes about 7 per cent of the total hemoglobin and increases slowly 
until about the thirtieth week, when there is a much more concerted "switch" 
from ','-chain to l3-chain production (Bunn and Forget, 1986). 
On the other hand . hemoglobins have c i in ical s ign if icants . H b  A2 
appea rs in  adult red cel ls late r around six months of age, when fe ta l  
hemoglobin tend to disappea r (Bu n n  a nd Forget: 1 986). 
Hemoglobin  Genes 
The C t  l ike a nd {3 l i ke globi n subunits a re i ncoded by two cluste rs of 
genes each of which is expressed sequentia l ly du ri ng development. The 0:.­
ge nes are c luste red on the short arm of c hromosome 16 in a 25 kb (25 ,000 
base pa ir) region . I n  the a-c luste r the re a re t 'vvo expressed a-g lobin 
structu ra l  genes «(Xl and (X2) located less tha n  3 kb apa rt. Three othe r genes 
belong to this  c luste r; the emb ryon ic s genes and the pseudogenes l..jlexj 
and �fC;. Pseudogenes are genes that have se quence homology with the 
active genes but con ta i n  mu tations that pre vent their  expression.  The 
location of ex-l i ke g lobin genes a re shown in  figure 5. The O-glob 1n genes 
c luste r is  found on the sho rt  arm of chromosome 11 i n  a 50 kb reg ion . The 
a rangement of the emb ryonic 8-g lobin genes , the feta l Gy and Ay glob in 
ge nes, the is and � (adult) g lobin genes, as well as the pseudogene \VOl i s  
s ho wn i n  figure 5. 
Eve rf expressed g lobin gene has three exons (sequences most of 
which code fo r the globin cha ins ) and two i nte rvening sequences . The 
inte rvening sequences (IVS) a re t ransc ribed in er ythroid cel ls so that the 
in it ial R NA t ranscript is  a mosaic of cod ing and i nte rvening sequences. 
With i n  the nucleus RNA processing enz ymes excise the inte rvening 
se quences and l igate the coding  bloc ks together to assemble the f inal  
mRNA molecule .  The precise biochemical steps DNA sequences of man y 
normal  genes has indicated that the re a re p referred sequences (consensus 
sequences) at the boundaries of the coding bloc ks and the IVS . The IVS 
al wa ys beg in with the d inucleotide G T  and end with an AG (the so-cal led 
Cha m bon rule ). The DNA sequences of the human (X and �-globin genes 
as wel l  as a l l  the other genes of these c luste rs have been determined using 
cu rent rapid nucleotide sequenc ing methods (Antonarak is  et aI., 1 985). 
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5' IVS.l IVS.2 3' � 
31 32 99 100141 
5 kb 
rf1fll 0 fl 3' 
5' . .... IVS.1 IVS.2 
--fW 
3031 104 
Figure 5: The chromosomal  loca l izat ion and 
genomic organizat ion of the human genes. For 
every gene, black boxes represent coding 
reg ions, white boxes represent interven ing 
sequences, and hatched boxes are the 5'and 
3'untranslated regions. a.-G: a lpha-g lob in 
genes, 0-G: beta-globin genes. IVS-1 and IVS-
2: f i rst and second intervening sequence. The 
numbers below the area of coding sequences 
represent the number of the amino acid 
res idue coded by this particu lar sequence 








I t has been d iscovered that the hemolysates of newborn red cel ls 
were resistant to alkaline denaturation .  It was suggested that these cel ls 
contained a structural ly distinct hemoglobi n .  This conclusion was 
strengthened by the demonstration that the hemoglobin from a newborn 
had i ncreased absorbance i n  the ultraviolet spectrum, a find ing now known 
to be due to an additional tryptophan residue in the -I chain . Subsequently, 
N-terminal amino acid analysis showed that the alkali-resistant hemoglobin 
of the newborn did i ndeed differ from normal adult hemoglob in .  The 
development of chromatograph ic  and electrophoretic techniques enabled 
the isolation and characterization of human fetal hemoglobin (Hb F) (figure 
6). More precise N-terminal analyses of purified H b  F suggested that it was 
a tetramer with two identical subunits in common with Hb A (ex chains) .  
However, the two other subun its had a common structure d ifferent from 
either of the subunits of H b  A, which is called gamma ("I) chains. The 
gamma chains l ie near the gene for beta chains on human chromosomes 
number 1 1; the gene for alpha chains resides on chromosome 16 (Bunn 
and Forget, 1 986). 
Hemoglobin F is the major hemoglobin in fetal life. It constitute 90 to 
95 per cent of the total hemoglobin in the fetus until about 34 to 36 weeks of 
gestation . The fetal hemogiobin concentration in blood decreases after birth 
by approximately 3 per cent per week and is  general ly less than 2 to 3 per 
cent of the total hemoglobin by 6 months of age.  This rate of decrease in 
Hb F production is closely related to the gestational age of the infant and 
does not appear to be affected by the changes in environment and oxygen 
tension that occur at the time of birth (Segel and Oski ,  1 990). 
Near the time of birth,  synthesis of gamma g lobin IS almost 
completely switched off, while synthesis of beta globi n  is  switched on . How 
such switch ing occurs remains one of the major unsolved problems of 


















Figure 6: Analysi s  of human umbi lical cord and 
adult  blood hemolysates by gel 
e lectrofocus ing, The ge ls  have been overload 
in order to demonstrate Hb A2 (from: Bunn, and 
Forget, 1986, p: 62 ) . 
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F CELLS and Hb F EXPRESSION 
1-F Cel l  Definition 
Red cells of newborn infants have a higher mean corpuscular 
volume and hemoglobin concentration than normal adult cells and show 
many differences in their metabolism. Fetal red cells differ from those of 
adults with respect to the activities of glycolytic and non-g lycolytic enzymes, 
carbohydrate consumption and ATP and phosphate metabolism. One 
easily detectable difference is the markedly reduced level of red-cell 
carbonic an hydrase, the most abundant non-hemoglobin protein of the red 
cel l ,  i n  fetal as compared with adult red cel ls . I n  addition there are a variety 
of changes in the red-cell  antigens; in particular the i antigens are 
expressed on the cel l surface (Weatherall and Clegg,1981). 
Small amount of hemoglobin F are found in al l normal adult. The 
majority of adults have less than 1 % hemoglobin F but there is a broad 
scatter of values rang ing from about 0.3 to 1.2% with a skewed d istribution 
(Benz and Schwartz, 1990). The amount of scatter is greater in females 
who as a group probably have a slightly h igher mean level of hemoglobin  F. 
Note here , these adult levels are not reached unti l after puberty 
(Wood,1989). 
The small amount of H b  F produced during post natal life are 
confined to a smal l subpopulation of red cel ls called F cel ls .  The numbers 
of F cells produced and the (Hb F/F cel l) content of these cells appear to be 
genetic polymorphisms (Dover et a I . ,  1981). F cells seem to be adult cel ls 
carrying Hb F, and are distinct from true fetal red cel ls  (Benz and 
Schwartz,1990). 
It has been established with immunological tech niques that normal 
aduits contain 0.2-7% F cells. The proportion of F cells is l inearly correlated 
with the percentage of hemoglobi n  F i n  the peripheral blood when the latter 
is either within the normal range or under cond itions in which it is s lightly 
e levated up to about 5% . This correlation suggests that the mean level of 
hemoglobin F per F cel l  remains constant in these conditions and that the 
12 
elevation of hemoglobin  F results from an increase i n  the number of F cells 
rather Increased production of hemoglobin F per red cel l .  Calculation of the 
mean hemoglobin F per red cel l from the percentage of F cel ls ,  mean cell 
hemoglobin, and the percentage of hemoglobin F in the blood gives a value 
of 4-8pg (Weatherall and Clegg,1981). 
Serial  studies on individuals over periods of up to 1:\..,0 years show 
that the F cel l level remains constant and reproducible, and furthermore 
once the adult level of hemoglobin F and F cel ls IS reached it appears to be 
relatively constant. 
Separation of peripheral blood cel ls according to age by 
centrifugation produces no difference in the distribution of F celis, arguing 
that they have a simi lar l ife span or turnover as non-F cel l s .  
Two possible models for the origin of adult F cel ls were set out. The 
first suggested that there might be a dist inct stem-cel l  population which 
gives rise to F cells and another to adult hemoglobin containing cel ls . The 
second suggested that both F cel ls and hemoglobin A conta in ing cel ls are 
derived from the same stem cel l  population. There is now reasonably good 
evidence drived from both in-vitro culture techniques and from studies of 
the distribution of F cel l  number in various clonal myeloproliferative 
disorders that both F cel ls and  adult-hemoglob in  conta in ing  cel ls are 
derived from the same stem-cel l  population and that F cel ls represent a 
subpopulation of cells that are derived from termina l maturation of less 
differentiated red cel l  progenitors (Weatherall and Clegg, 1981). 
2-H b  F expression 
Red cells of newborns conta i n  80:: 10 per cent Hb F. The amount of 
H b  F drops continuously during the first six months of l ife , owing to a 
progressive decrease i n  the synthesis of H b  F. The rate of decl ine of H b  F 
is  s lower i n  babies born prematurely as wel l  as in infants of diabetic 
mothers and in those with D trisomy. In contrast, infants with Down's 
syndrome and with C/O translocation have precocious synthesis of Hb A 
13 
and therefore a more rapid decline in the amount of H b  F (Bunn  and 
Forget,1986). 
During early childhood, there is a further decrease in Hb F .  About 80 
per cent of children SIX months to two years of age have g reater than 1 per 
cent H b  F, whereas only 4 per cent of normal adults have greater than 1 per 
cent (Bunn and Forget, 1 986). 
The smal l  amount of hemoglobin F present in adu lt red cells is 
restncted to between 0.1 per cent and 7 per cent of the total red cells . It 
also appears that in most normal adults the proportion of F cells remains 
relatively constant throughout life . However, there are wide range of 
conditions in which hemoglobin F production may be increased over that 
seen in normal individ uals (Bu n n  and Forget,1986). 
An elevated level of hemoglobin F i n  adult life may result from a 
genetic disorder of hemoglobin production or may be acquired in a variety 
of different hematological conditions .  There is increasing evidence that the 
underlying mechanisms for increased hemoglobin F production in these 
various disorders are quite different in each case (Weatherall and 
Clegg,1981). 
3-Factors Affecting H b  F Production 
Hb F production is under the control of many factors, genetic and 
nongenetic . 
a-Nongenetic Factors 
i-Physiologica l  Factors 
Many physiological factors a re involved in changes in Hb F 
production, of which pregnancy is the best known . 
-Fetal Hemoglobin and Pregnancy 
The most important condition in which there appears to be a 
physiological variation in the number of F cells is pregnancy 
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(Anyaegbunam et al.,1989). Here there is consistant elevation of the 
number of F cells at about mId-term, the level of which returns to normal 
towards the end of pregnancy (figure 7) (VVeatherall and Clegg, 1981). 
This elevation IS caused primarily by increased production of maternal F 
cells rather than by fetal red cells that have entered the maternal circulation 
through small breaks in the placental barrier (Dunn et al.,1989). Thus, F 
cell production is partially responsive to chorionic gonadotrophin and 
perhaps other hormones related to pregnancy (Bunn and Forget, 1 986). 
-Rapid erythroid regeneration 
There is increasing evidence that during periods of rapid 
regeneration after bone - marrow hypoplasia there may be a transient 
increase in the number of F cells and levels of hemoglobin F in the 
peripheral blood. This case has been well documented in patients 
recovering from bone - marro.,'.' depression following the transient 
erythroblastopenias of childhood, or infection, and less marked increase in 
F cell production has been observed within a week following treatment of 
iron deficiency anemia (Weatherall and Clegg,1981). 
ii-Acquired Disorders 
Some other physiological factors led to increase in Hb F production 
they are shown in table 1 . 
b-Genetic Factors 
The best known genetic factors affecting expression and elevation of 
fetal hemoglobin in adult life are the presence of gene mutations leading to 
hemoglobinopathies, in which populations are divided into at least two 
major groups: populations with high level of fetal hemoglobin and 
populations with low level of fetal hemoglobin. 
- Populations with high level of Hb F 
Many patients with sickle cell anemia (SeA) are known to synthesize 

























Figure 7: Studies of the sequent ial changes i n  
F cel l  numbers during pregnancy (from: 
Weathera ll, and Clegg, 1981, p:77). 
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Table l '  Acqu i red d isorders associated with 
e levated Hb F (from: Bunn ,  and Forget, 1986, 
p: 74) .  
16 
Cond i t ion 
Approx i m ate 
Frequency of r Hb F 
Approxlmatp. I?an'  j ,?  
of  % H b  F 
J u vc n i l c  chronic  myelo id  
l e u k e m i a  
Fanco n i 's a n e m i a  
E rYl h rolen kem i a  
E r y t h ro le u k e m i a  i n d uced by 
c h r o n i c  chemot herapy 
Paroxy m a l  noctli flw l 
h e moglobi n u r i a  
Re fracto ry a n c m i as-pre­
le u k e m i a  
A p l n s t i c  a n e m i a - fo l l owi n g  
m a r row e ngraftmcll t 
H }'d a t i d i form mole  
K a l a -azar  
A pl ast iC  a n e m i a  
Atl u l t  c h ro n i c  mye loid leu k e m i a  
A c u t e  l e u k e m i as 
Polyc� t h e m i a  ve ra 
M ve lof i brosis 
C hO r i ocarc i n o m a  
Osteopetrosis  
Tes t i c u b r  m a l i gnnncics 
B r o nch ogc n i c  Gucinoma 
J f e pnlOmn 
T h y rolox lco<;i� 
I n v ; HI :l I ' le  
Co m m o n  
Less corl l l l lon 
Up to I \ :'Yo 
2-RY" 
U p  to of )% 
. ,  
2-20 '"  
l - l ( n  
1-8 " (, 
I - I W;, 
1 - !  '2 "i, 
I - I ! n, 
1 - 1 0' i>  
I -W ; 
I - t; '  ;. 
l 1 p  I n  :0" ; 
2- 1 ') � 
U p  I I )  Iii'.'; 
Up 1 <  '22�, 
2- :O';'n 
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situations, the levels  attained are s o  h igh that the course of the disease is 
amel iorated si nce Hb F does not partici pate in the polymerization process 
characteristic of the sickl ing phenomenon (E I -Hazmi  et al . , 1 990). It has 
been reported that the s imu ltaneous inheritance of an cc. thalassemia gene 
reduces the severity of SeA (Charache,1990).  From the examination of 
levels of H b  F in Saudi  Arabians , there are at least two levels of Hb F (high 
and low) (AI -Awamy et a I . ,  1 986a). The eastern group of Saudi  Arabia is 
s ImI lar  to I ranian and some ind ians (Kulozik et a I . ,  1987) which have h igher 
Hb F l evels of 1 5-40% and m i ld  c l in ical  cond itions (AI -Awamy et 
al . ,1986b ;  E I -Mouzan et al . ,1989 ;  Pembery et al . ,1978 ;  Wood et 
aL,  1 980). 
-Popu lations with low level of H b  F 
The southwestern population of S audi Arabia has lower total 
hemog lobin and lower H b  F than the Eastern population has (Padmos et 
al.,1991) .  The southwestern levels of Hb F are s imi lar  to that of American 
and Jamaican populations .  In N i ger ians, the observations reported show 
that the levels of fetal hemoglobin are raised in SeA patients in this 
popu lation .  The Hb F levels obta ined (5.9%) are s imi lar  to those in 
Jamaicans ,  black Americans and  Brazi l ians with 5 .6% (Falusi  and 
Kulozik ,1 9 90), but are ,  however, marked ly lower than those observed in  
Saud i  Arabia and parts of I nd ia .  The levels of Hb F observed in  this 
popu lation are not very h igh  and the fetal hemoglobi n  levels observed may 
not affect the c l in ica l severity of their i l lness . The patients which are doubly 
heterozygous for the sickle gene and the Negro type of HPFH produce very 
mi ld symptoms,  and have feta l hemoglobin concentration i n  the range 1 5-
40% . The lower levels of H b  F found in  males compared with females 
(Adedej i  et al. ,1988) is sti l l  u nexpla ined since there is no evidence that 
there was selective loss through hemolysis of cel l s  with low amounts of this 
hemog lobin in femaies resu lt ing a h igher Hb F levels in them (Falus i  and 
Esan , 1 989). 
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I n  the Tun isian population the mea n  levels of  Hb F were not h igh 
com pa red to those observed i n  Senegalese and Saudi  Arabian popu lation . 
However the heterogeneity of H b  F expression in  each sickle cel l  patient 
(ranging from 2- 1 6%) could not be solely explai ned by age differences and 
is  presu mably u nder the control of  other factors yet to be discovered 
(Abbes et a l . , 1 991 ). 
In the Sudanese population , Hb F levels were s ign ificantly h igher in  
young s ickle ce l l  patients (below 10 years) than in  older patients .  However ,  
in  general i t  is  s l ightly d ifferent from black Americans and Jamaicans but 
d ist inctly d ifferent from Saudis .  The a mel iomting effect of Hb F seen a mong 
Saudi  populations was not observed (8ayoumi  et al ., 1 988). 
-Feta l Hemog lobin i n  UAE Population 
The present study atte mpts to examine  the a bi l ity of the UAE 
popu lation to synthesize Hb F and to com pa re it with other populations .  It 
attempts to demonstrate the mechanism contro l l ing this production of Hb F 
and the factors that contribute most to the d ifference i n  the Hb F levels 
among the UAE population . Th is  study is known to be the first studying the 
UAE population . 
PART I I : GOALS OF THE STUDY 
* - To establ ish the normal range of feta l hemoglobin expression In  UAE 
popu latio n .  
*-To compare other special g roups of popu lation in  whom there i s  a rise in  
feta l hemoglob in  expression (anemic ,  pregn a nt women and  tha lassemic 
fam i l ies) with normals .  
* -To exa m i ne whether there ' are variations i n  feta l hemoglobin expression 
within  the various groups of UAE population .  
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* -To demonstrate the importance of genetic determinant as opposed to 
envi ronmental determinant i n  the expression of fetal hemoglobi n .  
CHAPTER i t .  
SUBJ ECTS AND M ETHODS 
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CHAPTER I I .  
S U B J ECTS AND M ETH O DS 
-Su bjects 
A tota l 832 blood samples have been stud ied . Samples were 
obtained by venepuncture (2 ml) into EDT A as anticoagu lant .  Each sample 
has been stud ied at the hemological level and Hb F study .  Our study 
covered : 
- 26 1  pregnant women from the Obstetrics and Gynaecoiogy cl in ic .  
- 506 patients attending c l in ics for different reasons .  
- 6 5  �+ thalassemic patients studied a l ready at molecular  leve ls .  
The strategy was to perform : 
1 -Red Blood Cel l  Counts ( R .  B .  C .  ) 
2-F Cel ls Counts 
3-Fetal Hemoglobin Quantitation 
a-Alkal ine Denaturation 
b- Immunologic Method 
4-Hemoglobin Separation 
a-Cel l u lose Acetate Electrophoresis at  Alka l ine  pH 
b- Quantitation of  H b  A2 
-Methods 
1-Red B/ood Cell Counting ( RBG ) 
A com plete blood count (C .B .C .) , inc luding red blood count (RBC) , 
wh ite b lood count 0NBC) , hemoglobin level ( H b) ,  hematocrit (Hct) , mean 
corpuscular vol ume (MCV) , mean corpuscular  hemoglobin (MCH) , and 
mean  corpuscular hemoglobin concentration (MCHC) , provides valuable 
information with respect to the diagnosis of both aipha and beta 
thalassemia and for the norma l ,  anemic, and pregnant women samples. 
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The C. B.C. was done by Coulter Counter (type S plus) at the hematology 
laboratory in AI-Ain hospital . It gives the fol lowing parameters: RBC, WBC, 
Hb, Hct, MCV, MCH, MCHC, RDW. 
2-F Cells Counting 
F cells are small subpopulation of red cells that contain fetal 
hemoglobin. The acid elution cytochemical method adopted is a sensitive 
procedure which identifies individual cel ls containing Hb F even when few 
are present (Dade and Lewis, 1 9 91). F cells are conted in fresh blood 
under the microscope. A blood cel l  smear is prepared for each sample and 
Chiewsl ip  et al .  (1991) protocol has been fol lowed . 
Principle 
The identification of cells containing Hb F depends upon the fact that 
they resist acid elution to a greater extent than do normal cel ls ;  thus, in the 
technique described below, Hb A and its var iants are read i ly eluted from 
red cells on blood smears when incubated in acid/alcohol/amido black 
solution at pH 2 ,  whi le Hb F remains on the sl ide and appears as isolated 
darkly-stained cells amongst a background of paly staining ghost-cells 
(F igure 8). 
Technique 
1 ) The air d ried fresh blood smear (not over 24 hours) was fixed in 
80% ethanol for 3 min. 
2)  Then immersed in acid/ alcohol! amido black solution for 2 min at 
room temperature (1 00 mg amido black, in 1 00 ml of 80% ethanol , 
pH adjusted to 2 with He/) . 
3) The smear was washed with tap water for 1 5 seconds and air 
d ried. 
4) The stained smear was examined under an oil immersion lens. 
Figu re 8 : Acid e lution preparation from a periphera l blood smear showing F cel ls .  
5) Total of 1 00 cel ls were counted i n  the field and the percentage of 
F cel ls was taken accord ing to the number  of F cells counted in the 
field.  
3-Fetal Hemoglobin Q uantitation 
In order to q uantitate the total amount of feta l hemoglobin ,  mo 
different techn iques have been used . 
a-Alkal ine denaturation 
B lood Washing 
The anticoagulated b lood was washed with isotonic solution (sal ine 
solution NaCI 0.9%) and red blood cel ls were used for fetal hemoglobin 
determination . 
Blood washing procedure 
1 ) Whole blood was added with an equal  volume of sal ine solution 
(NaCI 0.9% ) .  
2 )  Di luted blood was centrifuged for 1 0  m i n  at 2000 rpm . 
3) The supernatant was removed by a vaccum pump. 
4) This operation was repeated 3 times unti l  the supernatant 
becomes very clear .  
Principle 
Among a l l  hemoglobins (Hb A ,  Hb A2 , Hb S etc . .  .) the Hb F is 
resistant to a lka l ine  denaturation . This characteristic can be used to 
determine the amount of Hb F in  a solution (hemolysate) conta in ing Hb F .  
To measure the percentage of Hb F i n  a m ixture of  hemoglobins , 
denaturation is  made by addition of sod ium hydroxide (NaOH) for a g iven 
time,  and stopped by adding saturated ammonium sulphate. The 
ammonium sulphate lowers the pH and precipitates the denatured 
hemoglobin .  The a bove m ixture is centrifugated I and two layers wil l  appear: 
a preci pitate of denatu red hemoglobin and supernatant conta in ing fetal 
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hemoglobi n .  The proportion of a lka l i -resistant ( i .e .  fetal) hemoglobin is  then 
calcu lated as a percentage of the total amount of hemoglobin present 
(Dacie and Lew; 5 , 1 99 1 ) .  
Technique 
The amount of fetal hemoglobin is  obta ined by measuring the 
absorbance density of the supernata nt against a contro l . 
-prepare a hemolysate as fol lows:-
a- 300 � of washed red blood cel l .  
b- 4 m l  Drabkin (3% potassi u m  cyan ide ,  3 %  potassiu m  
ferricyanide) . 
Reactions 
-Prepare the fol lowing reaction tubes : 
Control Dosage (Test) 
Hemolysate 1 400111 1 400�.LI 
NaOH 200�!1 
Water 200l-li 
Allow to react for exactly 2 minutes and then add the fol lowing:  
1 000).11 
Allow to stand for at least 5 minutes then centrifuge at 2000 rpm for 1 0  
minutes. 
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-Di lute the control to 1 /20 (200 �!I hemolysate + 3800 �I H20) . 
- Al low to stand for 5 min . at least and centrifuge for 1 0  minutes at 2000 
rpm ; two phases wi l l  apear: 
i- the supernatant (conta ining the Hb F) . 
i i - the prec ipitate conta in ing the other types of Hb .  
-The upper solution is removed carefu l ly and the absorbance is read at  540 
n m  aga inst the contro l .  
The a mount of Hb F is  done by the equation :-
Absorbance of Dosage (Test) 
Absorbance of Control 
* 1 00 =q,o HbF (Fucharoen et a l . ,1989) 
b- Immuno logic method 
Fetal hemoglob in can be measured immuno!ogical ly by using radia l  
immunod iffusion (R ID) with an antibody specific for Hb F (Adams a nd 
Stein berg,1991). Helena laboratories (b )  protocol has been fol lowed . 
Antiserum specific for Hb F is incorporated in  the agarose gel of the 
QUIP late. Hb F Standard and patient hemoglobin d i l utions (antigens) are 
appl ied to wel ls  i n  the agarose. The antigens are a l lowed to d iffuse into the 
agarose matrix where Hb F in the sampie react with the Hb F antiserum, 
producing an opaque precipitin r ing around the wel ls .  The precipitin r ing 
diameter for each standard and sample i s  measured after 24 hours of 
incubation . The diameter squared of the precipit in r ing is  d i rectly 
proportional  to H b  F concentration at the end of incubation.  A reference 
curve is prepared from the standards and used to determine the Hb F 
concentration in the samples . 
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Techn ique 
i .  Preparation of sample 
1) Determine the total hemoglobin concentration using a standard 
laboratory method (Dacie and Lewis,  1 991 ) .  
2) Di lute 0 . 1 m l  of the sample with purified water for a final 
hemoglobin concentration of 1 .0 g/d l .  U se the fol lowing table to 
determ ine the amount of p urified water requ ired . The fol lowing table 
l ists the volume of purified water to use in the sample d i l ution . 
3) Round off the total H b  concentratio n  to the nearest 0 .5  g/d l .  
4 )  Find the volume of water i n  the table to  be  added to  the 0 . 1  m l  of 
whole blood sample. 
Hb H2O Hb H2O Hb H2O 
2 0 8 0 .6 1 4  
2 .5 0 .05 8 .5 0 .65 1 4 .5 
3 0 . 1  9 0 .7  1 5  
3 .5 0 . 1 5  9.5 0 .75 1 5 .5 
4 0 .2 1 0  0.8 1 6  
4.5 0 .25 1 0.5 0 .85 1 6.5 
5 0 .3 1 1  0.9 1 7  
5 .5 0.35 1 1 .5 0 .95 1 7 .5 
6 0 .4  1 2  1 1 8  
6.5 0 .45 1 2 .5 1 .05 1 8 .5 
7 0.5 13 1 . 1 1 9  
7 .5 0.55 1 3.5  1 . 1 5  1 9.5 
5) After d i l ution ,  ag itate samples to ensure complete hemolysis 
wh ich i s  essentia l  to the accuracy of the test. 
6) This preparation wi l l  be used for appl ication on the H b  F QUIPlate 
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7) For samples conta in ing g reater than  10% Hb F ,  add 0 .1 ml  of the 
previous hemolysate to 0.9 m l  of purified water to make a 1 : 1 0  
d i lution to be used for appl ication o n  the H b  F QU IPlate after m ixing 
it wel l .  
i i .  QUIP late preparation 
Al low the plate to come to room tem perature . The plate can be 
opened easily by placing a th umb and forefinger on each of the plate 
flanges and then ffii sting the sections apart. Remove excess 
moisture from the wel ls if p resent. 
i i i .  Appl ication of Standards and Samples 
1 )  Apply 5 �d of each Hb F Sta ndard (0.5%,  5% and 1 0%) to three 
separate wel ls on the plate us ing a m ic rodispenser. 
C AUTION : Damage to a wel l  during appl ication wil l  resu lt in 
asymmetric precipitin rings and erroneous resu lts. 
2) Apply 5 pi of each di luted patient sample to separate wells in  the 
plate. 
iv. Incubation 
1 )  Place the cover on the p late and put it in the H u midity Chamber. 
E nsure that the top and bottom flanges do not ai ign with each other. 
2) Incubate the covered plate a min imum of 24 hours at room 
tem perature ( 1 5C to 30° C). 
Note: The plate incubation time (24 hours) must not be shortened. 
Incubation  for less than 24 hours wi l l  cause erroneous results . 
3) Remove the plate from the chamber at the end of incubation . The 
plate can be read at this time or after storage . 
v. Prec ip itin ring measurement 
1 )  Position a precipitin r ing u nder the QUIP Comparator (ocu lar) . 
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2) Hold your  eye as close as possib le to the ocular for accurate , 
reproducib le readings.  
3) Read the r ing d iameter to the nea rest 0.1  m m  and record . 
vi . QUIPlate reuse 
If some wel ls on the QUIPlate a re not used , the covered plate may 
be stored at 2° to 6° c in a humid ity chamber .  Under these storage 
cond itions,  a plate may be reused for u p  to 28 days without 
establ ish ing a new reference curve .  The p late can be used after 28 
days if a new reference curve is  establ ished .  
vi i .  Calcu lation of resu lts 
1 )  Prepare a refe rence curve using the graph paper provided. Plot 
the known sam ple  concentration (x-axis) against the r ing diameter 
squared (y-axis) for each H b  F Standard .  Draw a straight l i ne-of­
best-fit through the points. 
2) Using the square of the diameter of each sample prec ipitin r ing 
va lue ,  read the %Hb F from the reference cu rve. 
3) Results for samples with Hb F val ues betvveen 0 .5% and 1 0% are 
read d i rectly from the reference curve.  
4) Results for samples conta in ing g reater than 1 0% Hb F m ust be 
mu lt ipl ied by a d i lution factor of 1 0  to obta in  the fina l  value .  
4-Hemoglobin Separation 
a-Cel lu lose Acetate E lectrophoresis at  Alka l i ne  pH 
Principle 
Electrophoresis on cel l u lose acetate membrane is one of the best 
methods for separating abnormal hemoglobins .  This method is simple, 
rapid a nd sensitive. It is genera l ly satisfactory for d istingushing the 
com mon hemoglobin variants. 
At a lka l ine pH (8 .4 - 8 .6) hemoglobin is a negatively charged protein 
and in  an electric fie ld wil l  migrate toward the a node (+) .  Most structural 
variant of hemoglobin wi l l  separate due to surface charge d ifferences, thus 
a l lowing identification of abnormal forms. 
Technique 
Dacie and Lewis (1991) protocol has been fol lowed . 
1 )  F i l l  the compartments of the electrophoresis tan k  with TEB buffer 
(Tris/EDTAIBorate (TEB) , pH 8 .5) . Tris - (hydroxymethyl) - amino -
methane 1 0 .2 g ;  ethylened iam inetetra - acetic acid (EOTA) 0.6 g ;  
boric acid 3 . 2  g ;  water to 1 l iter .  Soak and  position the wicks of fi lter 
paper, the outer edges should be in the buffer. 
2) In a separate d ish soak the cel lulose acetate membra nes in TEB 
buffer for at least 5 min.  It is  i mportant to i m merse the membranes 
slowly so as to avoid trapping a i r  bubbles. 
3) Blot the membranes between mo pieces of absorbent paper, but 
do not a l low to d ry out before a pplying the hemo/ysates . 
4) Lyse the washed blood (packed cells) by adding to it 2 vol umes of 
disti l led water .  After shaking ,  centrifuge the mixture at 2000 rpm for 
1 0  m in .  
5) Place a smal l  volu me (1 0 1-11) of the top layer of each hemolysate 
sam ple in a sample wel l  i nto which the a ppl icator is d ipped in order 
to transfer the sample to the cel lu lose acetate membrane. 
6) Apply the hemolysate samples to the cel l u lose acetate 
approximately 2 cm from one end of the strip .  Al low the applicator 
tips to rema in  i n  contact with the strip for approximately 3 seconds.  
7) Place the strips upside down i n  the tank  so that the wicks are in 
contact with the buffer and the cel lu lose acetate so that the 
appl ication l ine is toward the cathode .  
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8) Apply the power and run at 250 - 350 V for 20 min or until 
adeq uate separation is obta ined.  
9) Switch off the power, rem ove the strips from the tan k  and stain  for 
3 - 5 min with Ponceau S ( Prote in  sta in :  Ponceau S (4 g/1 00 ml)  in  
trich loracetic acid 5 % .  
1 0) Remove the strips, dra in  and e lute the excess stain with three 
consecutive 1 5  min washes with desta in ing solution (5 % (v/v) acetic 
acid , 50 mill) then air  dry. 
1 1 )  Make certa in  the strips are adequately labelled and place i n  a 
protective container, e .g .  a p lastic envelope .  
b- Quantitation of H b  A2 
Principle 
The accurate quantitation of hemoglobin A2 (Hb A2) in the c l in ical 
laboratory is essential for the d ifferentia l  d iagnosis of several anemias and 
the thalassemias . E levated H b  A2 is widely regarded as sufficient evidence 
for the d iagnosis of p-thalassemia trait . The Helena Beta - ThaI Hb A2 Quick 
Column is an an ion exchange chromatography method.  The anion 
exchange resin is a preparation of cel l u lose covalently coupled to smal l  
positively charged molecules. The positively charged cel l ulose attracts 
negatively charged molecules . Prote ins ,  such as the hemoglobins,  conta in  
many positive and negative charges due to the ionizing properties of the 
component amino  acids. In the a nion exchange chromatography of Hb A2 , 
buffer and  pH levels are control led to cause d ifferent hemoglobins to 
possess d ifferent net negative charges. These negatively charged proteins 
are attracted to the positively charged cel lu lose and bind accord ingly. 
Fol lowing b inding,  the proteins are removed selectively from the resin by 
altering the pH or ionic strength of the elution buffer. Due to the pH of the 
resin  a nd the ionic strength of the H b  A2 Developer, Hb A2 does not bind to 
the positively charged cel lu lose and  i s  eluted as the developer moves 
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through the column .  The other normal and most abnormal hemoglobins are 
reta ined by the resin .  The Hb A2 fraction is compared to a total hemoglobin 
fraction by determin ing the absorbance of each usin g  a spectrophotometer 
and then calculating the percentage of Hb A2 . 
Technique 
Helena laboratories (a ) protocol has been fol lowed . 
1 )  For each sample quantitation to be performed obta in :  
1 Qu ik  Column from Helena laboratories 
1 Hb A2 Col lection tube (smal l) 
1 Total Fraction tube (large) 
2) AJlow the appropriate n umber of col umns and the reagents to 
come to room temperature before performing the test. 
3) Prepare the samples as fol lows : 
Lyse the washed blood (packed cel ls) by adding a drop of it to 
400 �d of d isti l led water. Vigorously shake the tube to achieve 
com plete hemolysis of the sample. Complete lysis of the 
sa mple is essentia l  for accurate results. 
4) Prepare the columns for use as fol lows: 
a .  Upend each col u m n  twice to remove any resin  from the top 
cap closure. Remove the top cap closure and completely 
resuspend the entire contents of the column using a Pasteur 
pipette with a smal l  rubber bulb .  Be sure a l l  the resi n  is 
resuspended above the filter .  
b.  Immediately after resuspension of each column ,  hold the 
column over a s ink or absorbant paper and remove the 
bottom tip closure a l lowing the buffer to drain . If the column is 
al lowed to stand  with the bottom tip closure in place, 
resuspension must be repeated . 
c. As the resin repacks, you wi l l  see an i nterface (with a s lurry 
above) slowly move u p  the tube. As soon as the slurry settles 
to form an interface of res in  and remaining supernatant 
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above, aspirate the undrained s upernatant (making sure not 
to d isturb the resin)  and  d iscard . 
d .  Place the column i n  the Qu ik  Column Rack al igned over a 
smal l  col lection tube . 
5) Slowly and careful ly apply 1 00pl of the hemolysate to the column .  
Dur ing appl ication,  do not a llow the sample to form bubbles or 
run down the side of the tube . Excessive force used du ring 
appl ication wi l l  d isturb the resi n  and may cause erroneous 
resu lts . 
6) I mmediately after sample appl ication to the column ,  add 1 00pl of 
the same sample p reparation to a Total Fraction (TF) 
col lection tube using the same Q u ickpette. Add purified water 
to the tube to the scribed l ine .  The total volume wil l  be 1 5  mL .  
7) Allow the sample to  completely absorb into the res in .  The 
hemolysate wi l l  have a g lossy appearance when viewed from 
above u nti l  the sample is completely absorbed by the res in .  
Upon complete absorption , the top of the res in  wil l  have a 
du l l ,  mat- l ike appearance. 
8) Following the absorption of the sam ple i nto the resi n  bed , slowly 
apply 2 .5  mL of Hb A2 Developer to the column .  Excessive 
force when applyin g  the developer may d isturb the res in  and 
cause erroneous resu lts . 
9) Allow a l l  of the Developer to pass through the column into the Hb 
A2 (small) col lection tube. The eluate conta ins the Hb A2 . 
1 0) add 0 .5 mL of p urified water to the smal l  col lection tube. The 
total volume wil l  be 3 mL. 
1 1 ) Invert both col lection  tubes several times to mix contents 
thorough ly. 
1 2) Determine the Hb Az percent in each sample using a standard 
spectrophotometer .  
a. Adjust the wavelength to 4 1 5 nm.  
b.  Zero the i nstrument with purified water. 
c .  Read and record the absorbance of both the Hb A2 
and TF col lection tubes . 
d .  Determine the H b  A2% by this  formula : 
Abs of H b A2 Fraction -----=---- "' 1 00 - H b A 0/0 5>i< Abs of TF Solution 2 
-In the form ula: 
*Hb A2% = percentage of Hb A2 i n  the sample. 
*Abs of Hb A2 Tube = absorbance of the contents of 
the small collection tube at 41 5 nm (Hb A2 fraction) .  
*Abs of the TF Tube = absorbance of the contents of 
the large col lection tube at 41 5 nm (other hemoglobin 
fractions) . 
*5 = dilution factor (1 5 mL of TF Tube /3mL of Hb A2 
tube =5) 
* 1 00 = percentage conversion factor. 
CHAPTE R I I I. 
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CHAPTER II I . 
R E S U LTS A N D  DATA P R E S E N TATI ONS 
A- Normal Population 
1 - Genera l  Characteristics 
A prel im inary study has been conducted on a normal sample 
consisting of 335 healthy subjects ( 1 27 females and 208 males) aging from 
less than one year to 85 years . I n  this  g roup no c l in ical symptoms related to 
anemia were observed a nd the hemoglobin level was a lways equal to or 
more than 1 2  g/dl (Appendix I) .  
2-Hematological Data 
Hematological data were obta ined using Coulter Counter,  type S .  
This device gives the total red blood corpuscular count (RBC) , hemoglobin 
level (Hb) ,  hematocrit (Hct) , mea n  corpuscu lar  volume (MCV) , mean 
corpuscular hemoglobin (MCH) , and mean corpuscular hemoglobin 
concentration (MCHC) , but we are interested only in  Hb, MCV, and MCH 
(Appendix I) . 
a-Hemoglob in  Level (Hb) 
In al l  our normal sam ple hemoglobi n  is always in the range of 1 2-
1 9 .4 g/d l ,  however, it is noticeable as expected that the amount of 
hemoglobin is h igher i n  males ( 1 2-1 9.4 gJdl) with a mean level of 1 4 .83 gJdl 
tha n  that observed i n  females ( 1 2- 1 5 .9 g/dl)  with a mean level of 1 3.02 g/dl 
(Table 2) . 
Table 2 :  The hematological data range and mean values among normal 
population . 
G E N E RAL MAL E C;  FEMALES PARAMETERS POPULATION 
TOTAL NO.= 335 TOTAL N O .=208 TOTAL NO.= 1 2 7 
RANGE 1 2  - 1 9 .4 1 2  - 1 9 .4 1 2  - 1 5 .9 
Hb 
1 4 . 1 8� 1 .74)� a 1 3 .02 � 1 .38) 
(gldl) 
MEAN VALUE 1 4 .83� 1 .5� 
RANGE 6 1 .2 - 1 02 .8 6 1 .2 - 99.8 68 . 1  - 1 02 .8 
MeV 
MEAN VALUE 83 .80� 6 .28) 83 .36G 6 .40) b 83 .02� 6 . 1 1 ) 
(fI) 
RANGE 1 8 .9 - 38.9 1 8.9 - 38.9 20.5 - 36 .3 
MCH 
MEAN VALU E  27 .36� 3 .43) 2 7 . 4 1 � 3 .87) C . 2 7 .52� 2 .59 ) 
(pg) -------- - - - - -- --- --
*Mean (± S .D. )  
At  P< 0.05 the two means between males and females were not  sign i ficantly different ,  using 
a t-test for the difference between two means (Sokal and ROhlf, 1 98 1 ; Ronald and 
Yates , 1 963) . 
a t-test for Hb= 4 507*1 0 -1 ' b t-test for MCV= 0.905 
c t-test for MCH= 0 . 399 
V) (J1 
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b-Mean Corpuscular Volume (MCV) 
The normal  MCV obtain i n  ou r  study ranges from 6 1 .2 fI to 1 02.8 fI 
with a mean level of 83 .80 fl .  This para meter is s l ightly h igher i n  males with 
mean level 83.36 fl than i n  females with mean level 83.02 fI (Table 2). 
c-Mean Corpuscular Hemoglobin (MCH) 
The mean value of this para meter is h igher i n  females than  in the 
males with respective mean values of 27.52 pg for females and 27 .41  pg 
for males, but it ranges from 20.5 pg to 36.3 pg i n  females and 1 8.9 pg to 
38 .9 pg in males (Table 2) .. 
3-Fetal Hemoglobin Expression 
a-Fetal Cells (F cel ls) 
Feta l cel ls (F cel ls) are a hemog lobin F conta in ing red blood cel ls .  
The presence of fetal hemoglobin in  the erythrocytes make them resistant to 
acid elution . The amount of F cel ls has been obtained by counting 1 00 cells 
in  a random m icroscopic fie ld .  The F cel l  appears darkly sta ined wh i le other 
erythrocytes appear l ight (Figure 8) . 
Accord ing to th is techn ique ,  the F cel l s  appear to be variable and 
d iffer from sample to another. The count ranges from 0%-4% in  males and 
from 0%-5% in females,  with a mean level 1 . 1 6% in males and 1 .29% in 
females .  However,  we have seen separate cases with h igh level of F cells 
namely 41 % and 44% in males (sa mples no. 6 and 1 0  respectively) and 
41 % in  one female (sample no. 289) . As mentioned in the hematological 
data , no noticeable d iffe rences have been observed between males and 
females (Table 3) (Figure 9, 1 0 , 1 1 ) .  
b-Feta l Hemoglobin (Hb F) 
This parameter is h igher in females tha n  the males with respective 
mean level of 0 .485% for females and  0 .430% for males , but it ranges from 
Table 3:  The Hb F % and F cells % range and mean values among normal 
population . 
PARAMETERS H b  F (%) F cell (%) 
TOTAL RANGE 0 . 1 04 - 0 .895 0 - 5  
POPU LATION 
MEAN VALU E  0 .449G O.� Jt 1 .23� 1 ) 
RAN G E  0 . 1 08 - 0 .89 0 - 4  
MALES 
MEAN VALU E  0 .430 6 o.2) a 1 . 1 6G 1 ) b 
RANGE 0 . 1 04 - 0.895 0 - 5  
FEMALES 
MEAN VALU E  0 .485G 0.2) 1 .29G 1 ) 
*Mean (± S .D . )  
At  P< 0.05 the two means between males and females were not  significantly different ,  using 
a t-test for the difference between two means (Sokal and Rohlf, 1 98 1 ; Ronald and 
Yates. 1 963) . 
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0. 1 04% to 0.895% in females and from 0 . 1 08% to 0.89% in ma les (Table 
3) (F igure 1 2, 1 3, 1 4) .  
B- Anemic Population 
1 -General Characteristics 
The subjects of this group a re selected accord ing to the amount of 
hemoglobin .  Individua l  having hemoglobin less than 1 2  gfdl are taken in 
th is g roup. This group consists of 1 71 anemic subjects (1 20 females and 
51 males) aging from less tha n  one yea r  to 80 years (Appendix / I) .  
2-Hematological Data 
S im i lar to the normal population hematological data were obtained 
by using Cou lter Counter, type S .  The whole hematological data , F cel ls% 
and Hb F% are depicted in  Appendix I I .  More detai ls about some 
parameters are g iven in the fol lowing  paragraphs.  
a-Hemog lobin Level (Hb) 
In th is group,  hemoglobin IS always less tha n  that which was 
observed in  the normal population (mean :  1 0 .44 gfd l ) .  However. we note 
that the amount of hemoglobin i s  h igher i n  females (1 0 .55 g/dl) than that 
observed in males who d isplayed a mean value of only 9.98 g/d l (Table 
4) . 
b-Mean Corpuscular Volume (MCV) 
The MCV ranges from 48.6 fi to 98 .4 fi with a mean level of 75. 7 1  fi . 
However, l ike hemoglobin the MCV is a lso higher in females than males 
(76 .03 fI and 74.95 fi respectively) (Table 4) . 
c-Mean Corpuscular Hemoglobin (MCH) 
Concerning th is parameter , we observed that there are many 
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Table 4: The hematolog ical data range a nd mean values among anemic 
popu lation . 
GENERAL M A L E S"  FEMALES I PARAMETERS POPULATION TOTAL 
NO = 1 71 ;fOTAl NO =51  TOTAL NO = 1 20 I 
RANG E 5. 8 - 1 1  9 5 8 - 1 1 9 6 1 - 1 1 9 
Hb 
(g/d l) 
MEAN VALUE 1 0.446 1 45) *" 9 98� 1 32) 11 1 0  55 � 1 1 4) 
RANGE 48 6 - 98 4 52. 7 - 91 .6 48 6 - 98 Ii 
MCV 
(ft) 
MEAN VALUE 75 7 1 � 9 2V 74 956 1 4 1 2) b 76 03� 9 4� 
RANG E 1 4.3 - 32 1  1 5 9 - 30.2 1 4.3  - 32 1 
MCH 
MEAN VALUE 24.06G 3 90) 24 026 3.25) c 24 086 3 44) 
(pg) 
"Mean (± S . D .) 
A t  P <  0 .05 the two means between males a nd females were not  s ign i ficantly d ifferent ,  using 
a t-test for the d i fference between two means (Sakal ard Roh lf, 1 98 1 ; Ronald and 
Yates, 1 963) . 
a t-test for H b= 0 . 024 b t-test for MeV= 0 .403 
c (-test for \I1 C H= 0 554 
�. ()l 
4G 
such as 1 4 3 pg , 1 5 9 pg and 1 7  7 pg This observation is expected c;ince 
we a re worki ng i n  a nemic subjects , having different causes of anemia . 
Howevel , no notic 3ble differences were obsel ved betw8en males and 
females. The mean level is around 24 pg for the whole an mic popu htion 
(Table 4) 
3-Fetal Hemog lobin E xpression 
a-Fetal  Cel ls (F cel ls) 
The presence of F cel ls was observed i n  blood smears from � memic 
patients , but with a broad i n dividual val iation . The F cel ls ranqed flOm 0% 
to 6% with a mean val ue of 1 . 81% (Table 5) . F igure 1 5  i l l u"trat s th 
distr ibut ion of th is ,parameter with in  the anemic population Un l ike the 
normal popu lntion , most n nemic patients had F cel ls in their blood Thi  
ind ica tes that a nemia is a condit ion i n  which the organ ism tpnd to 
compensate n nd there nre many young cel l s  conmin ing fetnl hemoglobi n  i n  
the b lood stream .  These F cel ls have a long l ife span Cl n d  thus IPmain 
vis ible i n  the blood smeClf. 
When F cells were compared i n  the same population between males 
and fem ales it appears that there is no s ignificant d ifference was obrerved 
between the two sexes in spite of a s l ight increase of the F cel ls mean value 
i n  males than the fema les (Table 5) (F igure 1 6 , 1 7 ) .  
b-Fetal Hemoglobin (Hb F) 
The d istr ibution of Feta l Hemoglobin (Hb F) in  anemic pati�nts is 
a lso heterogenous. However ,  most patients displayed normal vn l u,:>s , no 
more than 1 %. Some patients had Hb F more than 1 % and reached in  few 
pntients 1 .8% (F igure 1 8) .  
W e  know i n  t h i s  g roup that there was a possib le cnses o f  p 
thalassemia and this could be a reason for the increase in Hb F production 
I ndeed , patients with Hb F around 1 .5% to 1 .8% have hemntolog ica l 
Table 5: The H b  F % and F cel ls % range and mean va lues among anemic 
popu lation .  
PARAMETERS Hb F (%) F cell (%) , 
TOTAL RANGE 0 . 1 2 1 - 1 .864 0 - 6  
POPU LATION 
MEAN VALUE 0 .654G 0 .4) *" 1 .8 1 0(: 1 ) 
RANGE 0 . 1 2 1 - 1 . 793 0 - 6  
MALES 
MEAN VALUE 0 . 643G 0 .4) a 1 .93(: 1 ) b 
RANGE 0 . 1 3  - 1 .864 0 - 6  
FEMALES 
MEAN VALUE O.659G 0 . 4) 1 . 746(t 1 ) 
� Mean (= S O ) 
At p <  0 .05  the two means between males and females were n ot Sig n i ficant ly d i fferent ,  using a t-test for the difference between two means (Sakal and Rohlf  1 98 1 '  R on a ld ard Yates , 1 963) . 
a t-test for H b  F= 0 . 966 b t-test for F Cel l= 0 . 3 3 8  
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Figure 1 7 ' Distribution of F cel ls  o� amorg anemic male population .  
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52 
para meters with m icrocytic hypochromic a nemia character izing typical 1 \  
tha lassemia.  
The h igh level of  Hb F i n  th is  population does 110t coincide with tht: 
h i g h  level of F cel l s ,  i n d icating that the distr ibution of feta l  hemoglobin i r  
red cel ls could b e  heterogeneous i n  some cel ls a n d  homogenous i n  others 
When the Hb F expr ession is compared between males and 
females,  once agai n  no remarkable d ifference is  seen (Table 5)  a n d  both 
sexes displayed the same range of d istr ibution (F igure 1 9 , 20 ) ,  indicatinq 
that  there is n o  genetic determi n a nt l i n ked to  sex is affecting the 
production of feta l hemoglobi n .  T h i s  hypothesis wil l  be discLJssed later.  
c- Pregnant Women 
-. 
1- Genera l  Chara cteristics 
A total of 26 1  preg nant women were studied in 0 B . G .  c l i n ic of AI-Ain 
hospita l .  Pregn ancy was studied as an exam ple of a physiological state 
leading to cha nges in hematolog ical data a nd H b  F expression I ndeed , it is 
known that feta l hemoglobin can be detected in various stages of 
preg na ncy a n d  differs from one individual to a nother according to many 
factor s .  
T h e  a g e  o f  pregn ancy was at least 4 weeks and reached 40 weeks 
in some cases. Most women displayed a normal pattern of hemoglobin 
electroph oresis (Figure 21  a) .  However ,  5 women carried the sickle cell 
hemog lobin tra it (Hb S) (F igure 21 b) , a l l  of them have normal Hb A2 
(F igure 22) and normal  serum i ron .  Any woma n  h aving a b normal H b  Al. 
level or i ron deficiency was excluded i n  order to avoid a n y  misi nterpretation 
of h igh Hb F expression.  
2-Hematological  Data 
The general hematological data are depicted in Appendix 11/ a nd 
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Figure 2 1 : (a) Electrophoresis on cel lu lose acetate membrane at alkal ine pH 
shOWing separation of norma ! hemoglobi n .  (b) Electrophoresis on cellulose 
acetate membrane at a lka l ine pH showing separation of S tra it. 
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Figure 22:  Hb A2 expression i n  preg nant females.  Only females with normal Hb A2 
(2-3 .5%) were taken '1I1il consideration and stud ied for the erythrocyte ind ices and 
Hb F expressio n .  Females with low and high Hb A2 were excl uded . 
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Table 6' The h ematological data ra nge and mean va l ues among pregnant 
female populati o n .  
PARAMETERS PREGNANT TOTAL NO.= 206 , 
RANGE 8 . 1  - 1 5  
Hb 
M EAN VALU E  1 1  . 6SG 1 .6) * (gIdll 
RANGE 63 - 1 02 
MeV 
M EAN VAL UE 79 . 78(± 1 2 . 6) 
(ft) 
RANG E  1 9 . 3  - 36 . 5  
M C H  
M EAN VALU E  2 6 . 6� 3 . 2) 
lEg) 
* Mean (= S.D. )  
, 
I 
<Jl ...... 1 
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a-Hemoglobin Level (Hb) 
Th is parameter showed a difference when compared with the normal  
and a nemic populat ion. Indeed , the amount of hemoglobin  i n  preqnant 
women was 1 1 .65 g/d l ,  it came between the normal value observed in the 
female population which has a mean value of 1 3 .02 g/d l ,  and the anemic 
population with a mean va lue of 1 0 .55 g/dl (Table 7). This re ult is 
expected in sLlch a physiological state and the s l ight anemia observed here 
is most l i kely due to the increase in b lood volume observed d l l r ing 
pl egnancy. 
b-Mean Corp�scular Volume (MCV) 
The Mean corpuscu lar  volume i n  pregnant women ranged from 63 fI 
to 1 02 f1 (Table 6) . It a ppea rs that this para meter has a heterogeneous 
distribution . Pregnant females with the lower MCV presented with i ron 
defi ciency anemia due to increased demand for i ron dur ing pregnancy and 
lack of supplemental with i ron .  The one with the h ighest MCV ( 1 02 fl ) 
exhi bi ted a normal hemograrn i n  spite of a h igh level of regeneration 
(Appendix  I I I ) .  Using the MCV as an erythrocyte parameter ,  i t  appears that 
pregnant women exh i b ited a s l ight microcytosis in spite of a normal 
hemog lobin pattern . 
c-Mean Corpuscular  Hemoglobin (MCH) 
The mean corpuscular  hemog lobin observed in th is g roup ranged 
from 1 9.3 pg to 36.5 pg with a mean level of 26.6 pg (Table 6) . This value 
appears to be normal  when compared with the normal  population hav ing a 
mean value of 2 7.52 pg (Table 7) . The lowest MCH was observed i n  the 
same pregnant females having the lowest MCV. However,  the h ighest MCH 
is observed in a women with a p regnancy age of 28 weeks who exhibited a 
normal MCV of 80.6 fl . 
Table 7: The hematological data , F cel ls % and Hb F % range and mean va lues 
among normal ,  anemic , and pregnant female popu lation.  
PARAMETERS 
F Cel l  (%) RANGE 
MEAN VALU E  
H b  F (%) RANGE 
MEAN VALU E  
H b  (g/d l) RANGE 
MEAN VALU E  
MCV (fl) RANGE 
MEAN VALU E  
MCH (pg) RANGE 
MEAN VALU E  
�Mean (= S D.) 
Normal Female TOTAL 
NO = 1 27 
0 - 5  
1 29� 1 ) � 
o 1 04 - 0 895 
0 4856 0 2) 
1 2 - 1 5 9  
1 3  02� 1 38) 
68 1 - 1 02 .8 
33 02� 6 1 V 
20 5 - 36 3 
27 52& 2 59) 
I 
Anemic Female 
TOTAL NO = 1 20 
, 0 - 6 
I 
1 746(:t 1  ) 
o 1 3  - 1 864 
0.659� 0 4) 
6 1 - 1 1 . 9  
1 0 5s(± '  1 .  1 4 ) 
48 6 - 98. 4  
76 03 (t 9 42) 
1 4 3 - 32. 1 
24 08(:: 3 44 ) 
Pregnant Female 
TOTAL NO = 206 
0 - 4  
o 785 (± 0 8) 
0 - 2.24 
o 1 9(t 0.3) 
8 1  - 1 5  
1 1  65� 1 6) 
63 - 1 02 
79 7s(± 1 2 6) 
1 9 3 - 36.5 
26 6(t 32) 
.At p. 0 05 there s no sign ificantly d ifferent between normal females and a nemic females 




3-Feta l Hemog lobin E xpression 
The expression of fetal hemoglobi n  has been studied in  th is group 
by two approaches . The counting of F cells in a fr esh blood smear and the 
quantitation of feta l hemog lobin .  
a-Fetal Cel ls ( F  cel l s) 
The presence of F ce l ls i n  blood smea rs obtained from pregnant 
females gave a differ ent result .  The distr ibut ion (F ig ure 23)  showed that 
most fema les have no feta l cel l s  in their b lood smears. However ,  some 
pa tients exhibi ted a h igh level of 2 % ,  3% , and 4% F cel l s  in their b lood 
smears .  Most of these patients were pregnant women in advanced 
pregnancy, and the presence of F cel ls at th is  moment could be due to 
contam ination of maternal  b lood by feta l  blood , s ince it is known that F cel ls 
and Hb F as  a whc:
1e decrease in adva nced pregnancy This is  i n  
concordance with our result  because most of our sample i s  formed by 
pregnant women after mid term and showed a very low level of fetal cel ls as 
shown i n  figure 23.  
b-Fetal Hemoglobin (Hb F)  
The distr ibution of  fetal hemoglobin (Hb F)  i s  depicted i n  ' figure 24. I t  
appears that th is  d istr ibution is  paral lel to  what was observed i n  F ce l l  
d i str ibution . I ndeed , most pregnant females have no fetal  hemoglob in . One 
fem a le showed feta l hemoglobin reach ing 2 .24% and a lso had the highest 
level of F ce l ls . Th is  woman exh i bi ted a normal hemoglobin pattern having 
no � tha lassemia , but s ince she was in  the last weeks of pregnancy this Hb 
F level cou ld be explained by a contamination by the fetal b lood . 
0- D +  Thalas semic Patients 
1-Genera l Cha racterist ics 
It i s  known that r tha lassem ia IS a genetic condition i n  which the 
erythrocytic indices are mod ified and there is  a raised fetal hemoglobin and 
H b  A2 . I n  order to  evaluate the  place of environment in  the  expression of 
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Figure 23 : Distribution of F cells % among p regnant fema le population .  
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Note that females with 0% F cel ls are women with advanced pregnancy age 
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63 
fetal hemoglobin ,  f3+ thalassemic patients bearing the same mutation were 
studied . I ndeed , 45 heterozygotes and 20 homozygotes for the p IVS I-5 
mutation  characterized earlier (Quaife et a l . , 1 994) have been studied 
using the same strategy as for the above sam ples. 
The age of patients ranged from chi ldhood to adult age with different 
ethnic orig ins .  Most of these patients attend the cl in ic for hematological 
problems and some of the homozygotes needed blood transfusion .  
however,  i t  was taken i nto consideration that our  investigation has  been 
done when no interference of either blood transfusion or i ron deficiency 
were present. 
Appendix IV and V summarize the total hematological data . 
However our interest was main ly on the total hemoglobin expression and 
the erythrocyte indices, (MCH and MCV) . 
2-Total Hemoglobin Expression 
In  al l  homozygote patients the total hemoglobin expression was low 
compared with the obtained normal values. This hemoglobin ranged from 7 
g/dl to a maximum of 1 1  g/dl .  Most patients have a hemoglobin level of 9 
g/dl to 1 0  gJd l  (Fig u re 25).  
Concern ing heterozygotes , the hemoglobin level was markedly 
h igher (F igure 26) and most patients displayed hemoglobin level of 1 0  g/dl 
to 1 2  g/dl .  However,  3 patients had a hemoglobin level  a round 5 g/d/ to 6 
g/d l  indicating a very severe anemia associated with f3+ thalassemia.  On the 
other hand the d istribution showed strikly normal values of 1 4  g/dl and 1 5  
g/dl observed in adult males, most of whom were fathers . This observation 
is not surpr is ing s ince the heterozygous state of D tha lassemia  approaches 
the normal situation and exhib its a hemogram with only a sl ight 
modification .  The 3 patients having a low level of hemoglobin could have 
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3-The E rythrocyte Ind ices 
a-Mean Corpuscu lar  Vol u me (MCV) 
The mean corpuscular volume indicates the average of the cell size 
present  in the blood . It gives an idea of the hematopoietic s ituation of the 
patient and the hemoglobin content of the red blood cel l .  
I n  the heterozygotes r thalassemia subjects (F igure 2 7 ) ,  the MCV 
ranged from 55 t1 to 85 f! with a majority of patients having 60 t1 to 70 fl . 
Th is  i ndicates that those heterozygous for the same m utation could have 
different modes of regu lation of their hematopoiesis and production of 
hemoglobin .  
The homozygous patients having the same m utation on both 
homologous chromosomes show a wide s pread of the MCV (50 f1 to 85 fI) 
ind icating a very larg� degree of heterogeneity (F igure 28) . This  m utation 
leading to p . thalassemia appears to have different effects on d ifferent 
patients .  I ndeed , d ifferent fami l ia l  environment and medical care improve 
the c l in ical condit ions and ten d  to keep a min imum level of hemoglobin and 
MCV compatib le with a good l ife . 
b-Mean Corpuscu lar Hemoglobin (MCH) 
The d istr ibution of  mean corpuscular hemoglobin showed that 
heterozygote s u bjects synthesized a heterogeneous quantities of 
hemoglobin rang ing from 1 7  pg to 25 pg (F igure 29) , but most patients had 
1 9  pg to 22 pg . Fou r  patients displayed a higher value of 26 pg , 27 pg and 
28 pg. One patient had a very low MCH with 17 pg of hemoglobin but ,  this 
situation appears to be normal in heterozygous patients with p thalassemia .  
In  the homozygous state (F igure 30) the MCH is much more 
heterogenous ,  but not d istingu ishable in to g roups.  The d istribution is  very 
wide and each value is represented by one or two ind ividua ls .  
4-Fetal Hemoglobin Expression 
Concerning the B thalassemic samples , it  was not possible to study 
the F cell d istribution , these samples were a l ready studied at the phenotype 
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Figure 2 7:  Distribution of MeV (ft) among among heterozygou S f3 IVS I-5 mutation 
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level in  order to  determine the type of m utations The resu lts reported here 
a bout the feta l hemoglobin a re those obta i ned from the medical fi le of each 
patient . 
In the heterozygous state (fi gu re 3 1 )  it was observed that there is a 
heterogeneous d istribution of feta l  hemoglobin ranging from 0% to 4 5% 
with a gap between 2% and 4%.  Most patients had a fetal hemoglobin level 
of 0.5% to 1 .5%.  Only two patients had a fetal hemoglobin level of 4 .5%.  
They are adu l t  patients and fathers of  many ch i ldre n .  The relative low level 
of fetal hemog lob in  observed in these patients is not surpr is ing since in , , +  
thalassemia the decrease of p globin chain is l ight to moderate ,  and 
subsequently the com pensation by fetal hemoglobin (Hb F) appears to be 
low .  However, some patients expressed h igh level of feta l hemoglob in . 
In the homozxgous patients the d istr ibution of fetal hemoglobin 
(figure 3 2) is  clearly heterogenous with a discontinuous representation . 
The m in imum va lue was 0.5% and the maxi m u m  reached 31  % .  
Once again feta l hemoglobin i n  adu lt 0 +  tha lassemia i s  very 
heterogenous and each value might be interpreted separately accord ing to 
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'. CHAPTER IV. 
DISCUSSION 
C HAPTER IV. 
D I S C U S S / O N  
Hematolog icai data 
7 A  , .., 
The hematological  data and fetal hemog lobin expression presented 
in th is work concerned 4 different g roups of UAE population : the reference 
g roup ,  the anemic g roup ,  pregnant women g roup ,  and �+ thalassemic 
patients grou p .  
Concerning total h em oglobin expression a n d  the erythrocyte indices , 
we used the normal val u es obtained in our normal  population as reference. 
The normal  ranges for hemoglobin (Hb) ,  mean corpuscular  volume (MCV) , 
and mean corpuscular hemoglobin (MCH) are s imi lar  to those reported in  
other normal populations.  I ndeed , the normal h emoglobin was 1 4.83 g/dl 
for males and 1 3 .02 g/dl for fema les , the MCV was around 83 fl, MCH was 
2 7 .5 pg . These res ults a re not surprising because there are no 
physiological conditio n s  leading to changes in  h emoglobin concentration or 
eryth rocyte indices . 
The anemic population formed of 1 7 1 patients with hemoglobin of 
less than 1 2  g/d l ,  exh ib ited a characteristic pattern of microcytic 
hypochromic anemia with MCV of 75 f1 and MCH 24 pg.  The anemia 
patients were not subd ivided according to the cause of anemia. Certa inly 
there a re different causes for the anemia s uc h  as thalassemia 
(G ib(ett, 1 969 ; Klug and C umming,1 986 ; WeatheraH, 1 990 ; Emery and 
Mueller,1 992;  Olivieri , 1 992) or G-6-PD defic iency , and acqu i red , l ike iron 
deficiency or parasitosis (EI Hazmi ,  1 985) .  The para meters observed here 
ca n not be used as a model for anemic patients s ince many factors work 
together to give the p icture seen in our work. The determination of the total 
hemoglobi n ,  decrease i n  cel l  volume and the lack of pig ment withi n  the red 
blood cell are certa in ly d u e  to different factors genetic and environmenta l .  
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Most of our patients of this group had a d isturbed hemog ram and attended 
the c l i n ic for hematological i n vestigations. 
Pregnancy was used as one of the physiological factors leading to 
changes In  hematological data (Weatheral l  and Clegg, 1 981  ; 
Anyaegbunam et a l . , 1 989). However, th is  state depends o n  the age of 
p regna ncy and on the p roper conditions of each i n d iv idual  because a large 
n u m bers of our samples were obta ined from p reg n a nt wom e n  after mid 
term of  pregn ancy. We d id  not o bserve m uch variatio n  i n  the hemoglobin 
concentration . Indeed , the mean value of h emoglob in  was 1 1 . 65 g/dl which 
is less tha n  the normal val u e  but h igher than that observed in the anemic 
female popu latio n .  This val u e  a ppears to i ndicate the p resence of anemia 
but this condition is  observed i n  pregnant women a n d  it is most l i kely due to 
the s i mple p henomenon of increased blood vol u m e  and increased fetal 
hemoglobin d u ri n g  p regnancy.  
The � + tha lassem ic patients have been chosen in  order to evaluate 
the hematolog ical  data and fetal hemoglobin production i n  a homogeneous 
g roup bea ring the same genetic mutation cha racterized at the molecular  
level and known to us as the �+ thalassemia (� IVS I-5 G->C) (Quaife et 
a I . ,  1 994). This  g roup is characterized by a broad variation in a l l  
param eters . We coul d  not m easure a mean value a n d  took i nto 
consideration the ra nges. The total hemoglobin ranges from 7 g/dl to 1 1 .2 
g/d l  i n  the homozygous patients and 5 .6 g/dl to 1 5.9 g/d l i n  the 
heterozygous patients .  This large heterogeneity was observed in d ifferent 
patients of the same fam i ly i n dicating once more that hemoglobin 
p roduction is  under  many control l i n g  factors other tha n  genetics. 
The eryth rocyte indices MCV and MCH a re typical  of � thalassemia.  
There is a clear m icrocytosis in both homozygotes (MCV ranges from 50 fJ 
to 85 fJ) a nd i n  h eterozygotes (MCV ra nges from 55 fl to 85 fl) . It was 
establ ished that no i ron deficiency was i nterferi ng i n  these patients and the 
resu lts obta ined here are the p rofi les of � thalassemia o n ly and any other  
environ m ental factors leadi n g  to  a change i n  the hematolog ical param eters. 
The patients with a n  MCV of 85 fJ a re patients with an increased 
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reticu locytosis and presenting with a marked poiki locytosis and you ng cel ls .  
The MCH is  also variab le from one i nd ividual to another, but  a lways 
ind icating the typical hypochromia of p thalassemia patients . This 
hypochromia was remarkably i mportant in  some ind ividuals reach ing a low 
level of 17 pg . The quantity of hemog lobin withi n  the red blood cell of 
patients having the same genetic mutation appears very heterogenous, 
This leads us to thi nk  that the hemoglobin synthesis within  the red blood 
ce!1 is  mediated by the genetic background of each patient and the 
envIronment in which this  background is expressed . 
Feta i Hemoglobin Express ion 
Feta l hemoglob in (ai)'2) in adults persists normal ly in a smal l  
proportion of erythrocytes cal led F cel ls .  Synthesis of "I chains i n  these cells 
in probably completed very early  in their m utation and fetal hemog lobin 
represents only about 1 0%-30% of the hemoglobin of the fetal cel ls 
(V'Jeatheral l  and Clegg, 1981). Popu lation data indicates that among 
normal individuals, F cel ls frequency has a skewed distr ibution (Pembery 
et a l . ,1978 ; Weatherall and Clegg, 1981). About 3% of E u ropeans have 
more than 8% F cel ls and fami ly stud ies have i nd icated that th is is inherited 
as a heterozygous tra it from dominant gene (Bunn and Forget, 1986) . 
There is a lso good evidence that the erythrocytes conta in ing fetal 
hemoglob in have a longer l i fe span and subsequently are selected and 
protected against hemolysis (Rapaport,1987) .  Other works have 
demonstrated that feta l hemoglobin production is  u nder the control of many 
different genetic factors acting in cis with the gamma gene and in trans in 
other  locations (Bunn and Forget, 1986). However,  these works are sti l l  
incomplete because there are a lways many exceptions to  th is rule. Th is  
situation g ives place to other factors main ly environmental such as 
hormonal med ication and different p hysiological or pathological conditions. 
In  our work fetal hemoglob in has been studied to expla in some 
factors i nvolved in its production .  We used two d ifferent approaches to 
77 
qua ntify fetal hemoglobi n .  Four groups of populations were examined :  
normal population and th ree other  groups namely a nemic g rou p ,  pregnant 
women g rou p ,  and �+  tha lassem i c  patients grou p .  
The mean value of F cel l s  obta ined i n  the normal group was about 
1 . 2 %  according to our technique.  This val u e  a ppears to be in the normal 
ra nges observed in other populations (Chiewslip et aL, 1 99 1 ) and will 
constitute a good reference for the interpretation of our resu lts . There was 
no big d ifference betv.teen males and females who displ ayed a mean value 
of 1 . 1 6% and 1 .29% respectively. This d ifference was not statistical ly 
sign ificantly different. In the same group the p roportion of fetal hemoglobin 
a mong the total hemoglobin is  also similar in males and females and the 
mean level was a lways less than 1 % with a n  approxi mate value of 0 .5% . I n  
thi s  g ro u p  we d id  not observe a n y  correlation between fetal cel ls and fetal 
hemoglobin production and it was fai l ing to support the bel ief that i n  subject s 
with h igh fetal cel ls we observed a h igh level of fetal hemoglobin 
(Weatherall and Cegg,1 981). 
I n  the anemic group there were more F cel l s  i n  the blood smear and 
the average F cel l  was a round 2 % .  I t  is  evident that some patients had no 
fetal cells in their  b lood but most of them displayed a d ifferent p roportion of 
fetal hemoglobin .  I n  th is gro u p  also there was no d ifference between males 
a nd females.  The mean level for F cells in anemic males was 1 .93% , i n  
fem ales i t  was 1 . 746%. T h i s  d ifference was not s ignificant a n d  both males 
a nd fema les were considered to h ave the same range.  The conclusion from 
this g ro u p  is that fetal hemoglobin contin ued to be expressed in a nemic 
conditions and may be caused by genetic or environ mental factors. 
Pregna ncy was considered a physiological nongenetic condition i n  
which fetal hemoglobin could b e  present in adult blood (Anyaegbunam et 
a l . ,  1 989). In fact, p regnant women had a heterogenous d istribution of fetal 
cel ls with a mean val ue of 0 . 785%. This result is i nterpreted a s  a normal 
value.  We did not o bserve any a bnormal r ise in fetal cells p roduction most 
l ikely because of the age of p regnancy. Para l le l to Fetal cells the fetal 
hemog lobin proportion was a lso normal expressed heterogenously but with 
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a mean value  of 0 . 1 9% .  The results obta ined from the normal females and 
the p regnant women i ndicate that there is no sex l inked genetic factors 
modu lating  the feta l hemoglobin expression as reported in  some papers 
(Morris et a l . , 1 991  ; Dover et a I . ,  1 992) . 
The [3+ tha lassemic patients displayed a marked differences i n  fetal 
hemoglobin expression .  Unfortunately the feta l cells were not reported in  
th is work because i t  was not possible to do th is study when patients 
attended the c l in ic .  The resu lts of fetal hemoglobin are only those that we 
obta ined from the patients fi les. The fetal hemoglobin concentration was 
very heterogenous and there were a large variations from the heterozygous 
to the homozygous patients . I n  the heterozygous group the range was 
narrow and l im ited (0%-4.5%) . These d ifferences in expression are not the 
resu lt of genetic factors since we are dea l ing with the same mutation (f3 
IVSI-5 G�C) . Some other factors are responsible for fetal hemoglobin 
expression and could reflect hormonal , cel lu la r  and I or environmental 
variations.  However ,  the homozygotes patients exh ibit a large variation from 
0.5% to 3 1  % .  The b ig differences observed bet\veen patients with an 
identica l  genetic defect indicates that other  factors could be involved and 
g ive a d ifferent fetal hemoglobin expression . I ndeed the patients with high 
level of fetal hemoglobin (such as 24% and 31  %) are young female 
ch i ldren who have a delay in the feta l hemog lobin switch ing leading to a 
long pers istence of fetal hemog lobin which is  not observed in the other 
patients . This large d ifference in expression withi n  a homogenous genetic 
popu lation and sometimes withi n  the same fam i ly imposes the problem of 
fetal hemoglobin regu lation .  How can patients having the same genetic 
mutation  express d ifferent amount of fetal hemog lobin? 
Many suggestion  could be provided : 
S ince the feta l hemoglobin is a factor of improvement of the thalassemia 
condition and c l in ica l  symptoms as shown by Bardin et a l . , 1 989 ; Dover 
and Charache, 1 989 ;  Powars et a l . , 1 989 ;  Frankl i n , 1 990;  AI Awamy et 
al . , 1 991 , it could be understood that if there is  a good fol low up of the 
patient and good care there is no need for fetal hemoglobin production .  
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Surpris ingly,  th is hypothesis is untrue since many patients exh ibiting a 
rised i n  the level of feta l hemoglobin suffer from their d isease (EI 
Hazmi , 1 982;  8ayoumi et al . , 1 988 ; Awaad and 8ayoumi ! 1 993) .  However,  
patients with low level of fetal hemog lobin support the i r  thalassemia .  These 
controversial observations lead us to assume that fetal hemoglobin 
production could be under several determinants such as: 
-Genetic determinant which regulate the gamma chain production , th is 
depends on the i ntegr ity of the gamma gene and its environment. 
-The selection of erythrocyte conta in ing fetal hemoglobin (F cel ls) which 
survive longer than  the other cells (Bunn,  1 99 1 )  and by th is fact give rise to 
fetal hemoglobin .  
-A nongenetic factor reg ulating  the chain association with the heme in  the 
cytoplasm . 
CHAPTER V. 
CONCLUS ION S  
80 
C HAPTER V. 
C O N C L U S I O N S  
The production of fetal hemoglobin is u nder the control of many 
factors , the majority classified as genetic and the nongenetic factors . The 
nongenetic factors a re physiological factors ( i .e .  pregnancy, and rapid 
erythroid regeneration) and the acqu i red disorders .  The genetic factors a re 
the hemoglobinopathies which can be divided into the structural  variants 
( i .e .  sickle cel l hemoglobin) and disorders of synthesis ( i .e .  p tha lassemias) .  
Samples of normal  (nonanem ic) subjects , ar-gmic subjects , pregnant 
women and a group of p+ thalassemic patients of UAE population bearing 
the same mutation were studied for fetal hemoglobin expression and 
erythrocytic indices. The expression of fetai hemoglobin has been stud ied 
by tlNo approaches . The counting of F cells in a blood smear and the 
quantitation of fetal hemog lobin .  The hematological data of the samples 
have been provided by AI-Ain hospita l .  
From this study we managed to estab l ish a normal range reference. 
Also we conclude that feta l hemoglobin expression (fetal hemoglobin and F 
cells) is  very heterogeneous and not related to the sex. Furthermore , the 
environment plays a la rge  role in  fetal hemoglobin expression and on the 
hematoiogical indices as well .  
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AppendIx I :  The general characteristics and hematolog ical data among normal 
population .  
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Number Sex Age (year) Hb  (gJdl) MeV (fl) MCH (pg) F cells (%) Hb F (%) 
501 F ad. 1 2  1 0 .471  
83 F 27 \ 1 2.6 79.6 25.3  0 0 .478 
483 I F 30 I 1 3. 1 86 32 1 0 .484 
1 35 F 9 I 1 2.7  80.9 I 26.8 1 2 0.497 
302 F 1 5  1 2.4 85.3 28 0. 5 1 0  f-
363 F 29 1 2.4  82. 4 26.8 2 0.522 
1 52 F 30 1 4.3 I 81 .6  26. 1  1 0.534 
1 82 F 70 1 5.9  J. 1 0. 537 
437 F 24 1 4  84 27.2 I 1 0. 542 
1 24 F 33 1 4. 3  87. 9  1 28.7  J. 1 0. 547 
291 F 1 1  \ 1 3. 5  83. 5  i 27.6 J 2 0. 552 
31 2 F ad. I 1 2  84. 5 27.5 1 3 0.557 
381 F 30 1 2. 7  85 . 4  28 .4  : 0. 566 
98 F 20 1 3  90.9 I 29.8 1 0. 569 
243 F 30 1 3.2  91 .2 30.9 1 0. 580 
399 F 3 1 3.7 80. 4  26 .4  0.580 
207 F 7 1 2.7  78.5  i 25.6 0. 584 
427 F 48 : 1 2.7  72. 1 , 35.3  1 0. 586 
91  F ad. 1 2. 2  78.2 , 26.3  1 0.599 
409 F 30 1 2.9  85. 4 28.3  0.61 4 
348 F 36 1 2.7 81  1 26.6 2 0 61 6  
82 F 25 1 3  86.6 I 27.7 1 0.623 
351 F 22 1 3 . 4  I 1 0 630 
289 F 30 1 2.2 73.5 I 24 41 i 0. 632 
49 F ad. 1 2  87.5  I 28. 5  1 0. 644 
224 F 32 1 4. 1  J 1 0.646 
422 F 2.42 1 2.3 1 86.3 I 27.9 0 0.652 
439 I F 32 1 3.8 I 81 26.2  5 0.658 
273 I F I 1 1 2.2 ! 79.3  I 26.3 0.664 
1 54 I F 31  I 1 4. 1  I 87.2 28.6 0 0. 667 
360 1 F . 62 i 1 4.6  I 92.2 I 30. 5  3 0.675 I 
453 I F I ad. ! 1 3.4  I 82. 1 I 26.6 1 0. 676 
327 F ad. ! 1 4  I 86.4 ! 28 1 3 0.699 
1 02 F 24 I 1 2.4 89.8 I 29.6  I 1 0. 708 
205 F 1 3  I 1 2.6  79.8 , 26.4 I 3 0.71 0 I 
460 F 0.67 I 1 3.5  76 I 24.3 I 0.71 5 
41 7 F 7 1 2.8  , 76.8 I 24.9 I I 1 0.728 
I 1 3. 4  I 79.2 I 25.2 I 1 0. 736 31 8 F ad. I 
I I I , I 0. 746 309 F ad. 1 3.5  85.9 28.6 3 
347 I F 56 1 2.9 I 84.2 26.6 I 0 0.778 
294 I F I 25 I 1 4.4  I 85. 1 27.2 I 1 0.791 I 
221 I F , 42 1 2.9  I I 0 0.793 I 
324 I F I ad. I 1 3.3 I 91 .5  I 29.2  I 3 0.827 
455 I F I ad. I 1 3. 4  I 85.7 28. 1  0 .828 
320 I F I ad. I 1 2.8  I 85.6 28.4 I 2 I 0.831 
362 I F 30 I 1 4. 1  I 83.9 27. 1  I 0 I 0.833 I I 
353 I F I 20 I 1 3. 4  I 79. 2 I 25.4  I 2 I 0.846 
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N umber Sex Age (year) Hb  (g/dl) MCV (ft) MCH (pg) F cel ls (%) Hb F (%) 
5 M ad. 1 7.3 86 31 .5  3 0. 1 32 
1 1 1  M I ad. 1 6. 3  - I 94.6  31 . 2  2 1 0. 1 35 
390 M 36 1 7.3 1 83 23.9 I 1 0. 1 42 r -
389 M 48 1 5.6  J 87.8  28.8 I 1 0. 1 45 
35 M 29 1 5.3  1 89. 2  29. 7 0 1 0. 1 64 f-----
341 M ad. 1 6. 9  1 81 .2 26.2 2 i 0. 1 68 
479 M ad. 1 6  79. 1  25. 5 1 I 0. 1 69 
468 M 1 2  1 3 . 4  I 0 1 0. 1 70 
436 M 7 1 3.8 J 79 25.5 I 2 1 0. 1 71 
278 M 46 1 6. 1  I 78. 3 25.4 0 I 0. 1 78 
66 M 45 1 5.2  i 77.6 24. 3  0. 1 78 
392 I- M 32 1 5  
" 90.6 29.5 0. 1 79 
6 1  M ad. 1 5  I 92. 1 29.9 0. 1 80 
f- 259 M ad. 1 5.3  81 .2 26.6 0 0. 1 81 
67 M I 8 1 3.5  79. 1  25. 1  0. 1 81 
487 M 30 1 6  90 29. 5 1 0. 1 89 
81  M ! ad. 1 4.8  88.3 28. 2 0. 1 95 
1 1 0  M I ad. 1 5.2 82 -'- 26.6 0 0. 1 99 
476 M 1 7  1 3.8 76 24.4  2 0 .202 
75 M i 60 I 1 6.2  82.8  1 27.3 -'- 0 I 0.207 
379 M I 26 I 1 2.9  61 .2 1 8.9 I 0.207 
492 M I ad.  I 1 4. 5  81 .2  26.9 I 1 0.209 
475 M I 55 I 1 9. 4  91 . 2  29.7 I 1 0.21 3 
490 M I ad.  I 1 6.3  84.7 27.8 2 J 0.21 5 
41 4 I M : 25 1 5. 1  84.4 27.9 J ! 0. 21 6 
76 I M ad.  : 1 6  I 82.6 27 I 1 I 0.21 8 
1 41 I M 1 3  I 1 4. 1  ! 82.7 26.8 I ! 0.220 
1 1 6  I M 45 1 6. 4  I 81 .6 26.9 ! 1 J 0. 228 I 
84 M ad. 1 3. 1  1 80. 5 \ 26.3 1 1 0. 234 
70 M I 20 1 4.5  78.7 I 25. 1 I 0 , 0. 238 
1 71 M I ad. 1 3.4  83.4 I 27.2 1 0.238 
40 M I 3 I 1 3.8  79. 8  I 25.4 0 0 .239 
488 M I 22 I 1 4.5  81 . 2  I 26.2 1 0.240 
1 66 M I 53 I 1 4. 4  84.7 I 27.4 0 0 .242 ! , I , , 
345 I M I 35 I 1 3.2  , 86.3 I 28.2 I 0 I 0. 250 
79 I M I ad. ! 1 7  I 91 .3  29, 7  I 0.251 
279 I M 43 ! 1 4 .7  I 79.8 I 25.8 I 1 0.256 
90 I M ad. I 1 7.6  I 83.4 27. 1  I 0 I 0.265 
77 M I 26 I 1 7  I 93.3 I 30.9  I 1 0.265 I 
1 28 M I 25 I 1 4. 6  I 86.7 I 28.8 ! 3 0.272 
60 M I ad. , 1 7. 5  83 I 26. 5 I 0 1 0.273 I I I L I 
1 30 I M I 30 I 1 3  I 76.9 I 25.2 I 1 1 0.278 I 
2 I M , 37 I 1 3. 9  I I 86 I 30 I 4 l 0.278 
496 I M I ad.  ! 1 6. 7  I ! I 1 \ 0. 302 
380 I M I 24 I 1 4  1 89.3 I 24.2 I i 0. 302 
36 i M I 70 I 1 6.2  J 81 , 26.3 1 2 I 0.303 
1 26 , M I 40 I 1 6  I 88.6 I 29.5 I I 0.303 
90 
Number Sex Age (year) Hb (g/dl) MCV (fJ) MCH (pg) F cells (%) Hb F (%) 
73 M 50 1 2.6  64.7 1 9.6 0 0.306 - ----
1 65 M 25 1 5.4 -- , 87. 4 29. 1  0 0.31 1 
256 M 45 1 8 2 ! 96.5  32. 4 0 0.3 1 4  
493 M 4 1 3.2  I , 1 0. 31 4 -
41 3 M 8 1 3.9  77.5 23. 1  0.31 4 -
504 M 23 1 6.7  0 0.31 7 -
272 M 45 1 5. 5  90.3 29.5  0 0.321 
431 M ad. 1 6.6  84 26.9 1 0. 322 -
1 94 M 60 1 2  0.326 -
276 M 1 4  1 3. 3  76. 1 24. 5  1 0. 330 -
252 M 50 1 3.9  80.8 26 0 0. 336 
491 M 1 1  1 4. 1  82. 4 I 27 1 I 0.340 - --
393 M 29 1 5  83 : 29.5  0.347 
1 2  M ad.  1 5. 1  82 I 30.2 ! 0.348 
391 M I ad. 1 7.3  83 23.9 0. 349 --
57 M 30 I 1 6.2  89.9 I 29.2 0 0.350 
248 M 1 1  I 1 4. 1  33.6 1 0. 356 
261 M 28 I 1 6. 1  87.4 25.4  4 0.356 
264 M ad. i 1 4. 5  ! I 1 0. 359 
344 M 30 1 3.8  I 89.3 29.2  1 0. 364 
275 M 1 1  1 2.2  ! 74.3 24.5 2 0.375 
342 M ad.  ! 1 3.8  I 85.6 28. 1  4 0.378 
339 ! M ! 1 2  1 4. 1  75. 1 24.4 2 0.380 I 
1 27 M 28 1 3. 5  91 .7  30.6 0.383 I 
378 I M I 46 1 4. 7  79. 7 I 26.3 I 0. 384 
333 i M 45 1 4. 1  81 .2  I 26.2  1 .' 0.397 
447 I M t 1 0  I 1 3. 1  79. 7 I 24.8 0 0. 398 
349 M 40 ! 1 2.6  1 ! 0. 405 
301 M 1 0  I 1 2.3 80 9 I 25. 5  3 0.408 
471 M ad. l 1 4.7 83.2 27. 1  1 0 .41 1 
470 M i 25 I 1 6. 2  I ! 0 0 .41 5 
499 M I 36 1 2. 8  i I 1 0 .41 7 
486 M J 40 1 5.5  I 92.3 20.2 I 1 0.4 1 8  , I 
1 3  j M I 36 , 1 5.8  I 83 I I 30 i 0.41 9 
1 1 M I ad. 1 6. 1  91 I 34.7 0 0 . 422 L 
1 58 I M 38 I 1 5.6  , 79.6 I 26.2 1 0 .428 
1 86 I M 28 I 1 4.3  78.7 I 25 2 I 0. 428 , 
281 I M I 54 I 1 2.9  69.9 I 21 .6 3 i 0.432 t , 
430 M \ 33 I 1 4.6  ! 90.6 I 29 2 I, 0. 436 I 
1 63 M I ad.  I 1 2.9  I 83.5 I 27.4 I 0 I! 0.441 
1 04 I M I ad. 1 6.2 I 86.4 I 28.3 I 0. 443 
330 I M I 0.5 I 1 2  I I 1 0. 448 I 
41 1 I M : 4 I 1 4  I 80.8 27 I 0 .448 
89 I M I ad.  \ 1 6. 5  91 .2 29.5 I I 0. 467 
263 , M 35 I 1 7.2  I ! 1 0. 499 I I 
31 4 M 1 ad. I 1 6.3 1 86.7 28.3 I , 0.500 
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1 4  
1 6. 7  
1 5 . 4  
1 3. 7  
1 8  
1 5. 4  
1 4 9 
1 3. 5  
1 3. 9  
1 5.4  
1 6 4 
1 5 2 
1 4. 4  
1 5. 5  
1 2. 7  
1 5  
1 2.4  
1 5.3  
1 5. 9  
1 4 5 
1 4 9 
1 2. 9  
1 6. 9  
1 3. 8  
1 6. 5  
- -
1 2. 9  
1 7.6  
1 3. 9  
1 4.6 
1 6  
1 5. 1  
1 5. 2  
1 7.7  
1 6. 5  
1 4.2 
1 3. 2  
1 4  
1 7. 7  
1 4. 4  
1 6.2  
1 2. 5  
1 7  
1 3. 2  
1 7 2 
9 1  
MCV (fl) 
81 7 
MCH (pg) F cel ls  (%) . Hb F (%) 
26 1 0 0 51 1  
88 1 25.3 
84 5 27 2 
88 2 29. 1  
95 3 30.2  
81  25 6 
90 3 30.3  
83.6 28 
77.4 25. 6  
85 3 28. 1 
66 9 20.9 
81 6 26 
94. 8  30.9 
87 1 279 
84 4 27.5 
89.9 28. 9  
8 1  26.3  
86. 2  27. 8 
80. 2  25.9 
77 6 25. 1 
















84 .9  28. 5  
88. 7 28. 9  
30.3 
72. 1 22.4  
86.6 28.8 
84 8 27. 7 
84 8 28. 4  
9 1  30.3  
84 1 26.9 
89. 1 29.6  
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Number Sex �ge (year) Hb (g/dl) MCV (fl) MCH (pg) F cel ls (%) Hb F (%) -
245 M 35 1 6. 1 93.9 31 . 4  1 0 .705 
1 46 M 42 1 6. 2  9 1 . 2  30.4  0.820 - - - - - -
31 5 M 32 1 6. 1  0.821 - -
31 6 M 1 0  1 2.3  I 83.6 27.3 3 0.822 
58 M 38 1 5. 1  I 95 31 0.822 - --
20 M 3 1 2.7 82 27 .6 0 .825 - - - , 
1 25 M t-- - ad. 1 8. 1  85. 1 28 0 0.850 
502 M 30 1 7. 1  0 0.856 --
1 57 M 1 5  1 4 .7  83.3 22.3 1 0.866 
452 M 3 1 2. 2  80.2 26.6 0.866 -
505 M 25 1 4. 5  1 0 .882 
1 72 M 53 1 4. 1  99.8 33.8 0 0.890 
467 M 1 7  1 3. 4  : 81 .7 26.7 
96 M 31  ! 1 5  82. 1 I 26. 1 - .-
31 7 M 50 1 2  I 71 .8  I 21 .9 3 I 
1 69 M 33 1 4. 6  92. 5 I 29.5  0 - I 41 5 M 35 1 6. 5  88.5 i 28.8 
21 7 M ad.  \ 1 4. 9  87.3 i 29.7 I r-. I -206 M 8 1 2. 3  79.2 26 .4 2 
376 M I 30 1 2. 7  I 81 . 1  i 26.2 2 -
1 56 M 46 1 5. 5  I 88.9 I 28.6 1 
29 M ad. 1 5. 3  i 83 J 29.9 I 3 
503 M I 30 1 5.8 , I 1 
325 M ad. 1 6  81 . 5  I 26 1 277 M i 30 1 6.8  93.5 31 . 1  3 
44 M I 45 1 5.7 81  ! 27 1 458 M I 5 I 1 2  74.9 24.3 
466 1 M J 35 J 1 6. 4  I 86.6 I 28 .4  
235 I M 1 3  I 1 4. 2  24.4  1 
1 0  I M ad. L 1 6  I 80 I 29.5 44 
1 59 I M 30 1 5.3  I 86.9 28.5 
305 M 30 1 5.2  I 89.4  29.7  2 
268 M 26 I 1 2. 4  I I 0 I I 
1 79 M 50 1 4.2 I 79 24.7 I 0 
267 M I 22 1 3. 2  I I I a 
462 1 M I 1 3  I 1 3.3 I 84.9 I 28.2 I 
92 l M I 1 1 2. 9  I 71 I 22.2 I a I 
394 I M I 1 7  I 1 5  83.6 I 27.4 ! 1 I I 
371 ! M I ad. I 1 5.3  , 90.8 I 30.5 I 4 I I 
1 43 ! M , 70 I 1 2.4  I 80. 4 I 25.7 I I 
94 M 32 J 1 7. 4  I 88.2 I 38.9 J 1 1 I 
25 i 1 3.7  I 80.5 I 25.7 I a I 227 M I 
228 I M I 45 I 1 5. 2  I 78.8 I 25.8 I 1 I 
1 49 j M I 58 1 6.4  I 9 1 . 3  29.9 1 I I 
465 1 M I ad. 1 5. 3  ! 81 .3  I 25.8 I I 
1 38 I M I 1 1  I 1 2. 4  I 77.3 I 24.6 I 1 I 
21 6 I M I 1 1  I 1 3.7 I 85 I 28 I 1 I I I 
Number Sex 










Age (year) Hb (g/d l) 
0 03 
45 
1 7  
ad 






1 3. 7  
-� --
1 5  
1 4  
1 4. 2  
1 6. 2  
---
1 3 9 
93 
MCV (fl) MCH (pg) F cel ls (%) Hb F (%) 
. 
86. 2 27. 5 1 
77.2  24.7 1 
94 7 30. 5  1 
---
0 
78 3 25.5 2 
84. 1 27. 7  0 
80. 1  25.8 0 
94 
Appeno/x 1 / : The general characteristics and hematological data among anemic 
population .  
N u m ber Sex Age (year) H b  (g/dl) MCV (ft) MCH (pg) F cells (%) Hb F (%) 
31 1 F ad. " 1 0 .4  68. 1 21 . 5  2 0. 1 3  
�65 F 35 I 1 1 .9 91 . 2  30. 1 1 0. 1 39 
1 74 F 40 I 1 0. 4  83. 6 I 27.3 1 0. 1 55 
204 F 39 8 .5  I 0. 1 67 
357 F ad. 1 1 .9 : 77.6  I 24.6 ! 0 0. 1 76 
403 F 80 1 0. 4  83. 4  I 25.3 I 6 0. 1 85 
4 1 8 F 60 1 1 . 6 87 29. 2 2 0. 1 94 
1 45 F 1 3  I 1 1 . 1 I 70. 1 , 21 .6  2 i 0. 1 96 
1 92 F 25 8 .9 I 84.2 i 27. 6 I I 0. 202 
334 F 65 9 .4  j I 5 i 0. 204 
21 3 i F 70 8 .8 ! 86.6 , 27.5 1 0.208 
358 I F 22 I 1 1 .9 I 0.21 1 
232 F I 27 I 9 1  ! 72. 1 22.3  3 0 .21 5 
283 F I ad.  I 9 I 73 23.3 0 0. 227 
233 F 26 I 1 .0 .4  ! 74. 7  23.6 1 0.231 
375 F 55 I 1 0.8  93. 3  3 1  0 0. 232 
3 F ad.  I 1 1 . 1 I 70 I 23. 9 1 0 .233 
408 F 25 ! 1 1 . 4 75.8 25. 3 3 I 0. 236 
38 F 24 , 6. 1 54. 7 I 1 5.9  I 0. 238 
356 F ad. 9 73. 4  I 23.2 0.238 
88 F ad. 9.9 69. 4 , 21 . 7  ! 0.242 
355 F ad. 1 1 .9 93.7  j 30.9 I 1 0.247 
41 9 F 1 7  1 0. 7  71 . 1  ! 22.3 I 1 0. 248 
237 F 30 1 1 . 7  I 88 ! 29. 6 I 0.251 
372 F ad. ; 1 1 .5  75 . 2  I 23.2 I 5 0.267 
31 9 I F I ad. 9.8 75.8 I 23.5 I 0.274 
1 70 F 32 1 1 . 7 89.4  I 23.9 1 0 .28 
234 , F 32 1 0.8  83.8 I 21 .6  0 : 0. 289 
442 F ch.*' 8.9 ; 0. 296 I i 
299 F I 43 1 1 . 3  I 80.9 I 26 0.323 
236 , F , 30 9 .9 66.2 i 20. 1 0 .33 
1 1 3 F , 20 9.8 ; 76.3 I 23. 7  1 0.351 
1 67 F I 26 I 1 0.8  I 25. 2  0.371 
202 ; F I 35 1 1 . 1 I ! 0 0.371 
1 84 F 32 1 1 . 7 89. 4 I 28.9 0.374 
1 20 I F 30 , 1 1 . 4 73.6 I 24. 1 1 0. 375 
21 4 F 1 1  9 69. 4  I 22 1 0. 382 
56 F I 24 9.9 66. 1 r 20. 4  2 0. 393 
364 I F I 40 1 0.6  I 69. 4  I 21 .8  0. 402 
480 I F 35 I 1 1  i 4 0 .41 4 
1 03 : F ch. 1 1  76. 1 I 25.2 0 .41 8 
1 44 F 25 I 8.2  48.6 i 1 4.3  I 0 0.422 I 
72 I F 1 8  : 1 1 .6 I 91 t 29.3 I 0 0. 426 
78 i F 30 1 1 .9 I 80.2 I 25.9 I 0 0. 438 
209 ! F 28 I 1 1 .2 82.6 I 27 I 3 I 0 .44 
433 ! F ad.  I 1 1 . 5 I 82. 1 I 26.5 I 0. 449 
48 I F 8 I 1 1 . 4 81 .8  I 26.9 i 0. 457 
298 I F ad. I 1 1 . 2 I 88 I 28. 4 I 2 0. 459 
34 F 4 t 1 1 .3 8 1 . 7  I 26.7 I 0.465 
352 F 1 9  I 9. 1 I : 1 : 0 .467 
255 F ad.  i 1 1  I 0 0 .488 
495 F I 1 9  ! 1 0. 9  I i 0. 489 
336 F I 1 0  I 9.2  78 I 25.6 I 4 0. 493 I 
1 90 F ad.  I 1 1  79.7 I 25 ! 0. 496 
Number Sex Age (year) Hb (g/dl) -
1 22 F 26 1 1 .5 
21 5 F 1 08 1 1  -
249 F 25 1 0 8 -
448 F 26 1 1 . 7 -
21 0 F 45 1 0. 4  
247 F ad. 1 1  r- 46 F 27 7. 1 - ---- - --
27 F ad. -
62 F 22 � -
1 9  F 38 
24 F ad. 
251 F 65 - 1 00 F 38 - I 31 0 F ad. --
472 F 0 83 --
1 55 : F 40 
456 F ad. 
354 F 1 4  -
477 F ad. 
41 2 F 35 
384 F 50 
387 F 35 I- - -- ---- --1 21 F ad. 
300 F 28 
454 F ad. 
284 F ad. 
385 F 32 1-----322 I F ad. I 
25 F 30 i 
426 F ad.  
64 F 27 , 
4 1  F L-ad. I I- --- -274 F 30 I 
22 F 1 0  : 
269 F I ad. 
304 F ! ad. 
373 F i 0.67 
396 F ad. 
420 I F I 20 
293 I F I 50 I 
231 I F 70 I 
397 I F ad. I 
1 64 I F 4 I 
1 39 F 25 I 
421 F ad. I 
43 F I 26 I 
1 91 F I 70 I 
386 i F I 20 I 
50 I F I 20 
87 ! F I 38 
429 I F I 36 
297 I F ad. 
407 F 24 I 
450 F 30 : 
286 F I 26 i 
1 0.6  - -
1 1 .6 
1 0. 1  
1 1 . 4 
1 0.9  
1 1 . 2 
1 1 .5 
1 0  
1 1 . 3 
1 1 .3 
1 0 7 
9 .7 
1 1 . 7 
1 1  
9 .8 
1 1 . 1  
1 0.6  
7.6 
1 1 . 1  
1 1 . 7 
1 1 .2 
1 1 .8 
1 1 . 4 
7 .4  







1 1 . 7 J 
1 1 .2 
8.8 
1 0.7 
1 1  
1 0. 9  
1 1 .3 I 
7.8 
1 0.9  I 
1 1 . 6 I 
1 1 . 7 ! 
1 1 . 5 ! 
1 1 . 2 ! 
1 1 . 3 , 
1 1 .8 I 
1 0.6  1 
9.8 
1 0.6  
1 0.8  
1 1 .6 
1 1 .3 I 
9.9 I 
95 
MCV (ft) MCH (pg) F cells (%) Hb F (%) 
94.3  32. 1 0 0 . 499 
70. 5  21 . 3  � 0.504 
78.2 25 . 5  0.504 
85. 2  27.9 2 0. 505 
84. 5  27.8 I 0.51 2 
0 0 51 9  
59.7 1 7 7 1 0. 554 
82 27. 4  0. 567 
76 24.3 I 2 0.5is 
82 28.9 I 2 0.576 
81  24. 1 I 1 0 .591  
86. 6 27.7  -' 0.601 
75 .5 23. 7 I 2 0 603 
77 8 25. 1  1 0.6 1 4  
59. 7  1 8 5 ! 0.61 8 
75. 5  2 0.629 
75.5 23.8 6 0.663 
66.3 20. 4  0.683 
75 26 1 0. 709 
85 . 5  28.3  5 0.733 
69.3 21 . 5  0 0. 738 
65.7 i 20.4  2 0.751 
66.9 20 8 2 0. 768 
71 . 1  I 22.2 2 0.786 
55.2 28.2  0.8 1 2  
84. 4  26. 7 1 0 81 9  
75.5 I 25. 1 0 0.827 
78.6 , 24.7 -' 0 866 
75 26.8 2 I 0 877 
68. 5  21 .6  2 I 0. 962 
58.8 1 7. 2  ...: 0.967 
87.7 28. 5  1 0.987 - ----
65.6 20.2  1 1 0. 998 
67 24 3 1 .005 
i 1 1 1 .0 1 4  
63.8  1 9 . 4  1 1 . 079 
65.6 20.3  1 1 1 . 1 1 4  
69.5 I 22. 1 1 6 1 . 1 31 
57.6  1 7.9  J 5 1 . 1 37 
66.8 I 20.7 1 1 1 . 1 69 
76.9 ! 24.3 ! 0 1 . 1 73 
78.4 ! 25. 1 I 4 I 1 . 26 
79. 2  I 26. 1 I 1 1 . 3 1 6  
89. 6  I 29.7  I 1 1 .37 
87 I 27.3  2 1 .373 
76.8 I 24.3  1 . 422 
I 1 I 1 . 51 3 
83 1 26.9 1 I 1 .528 
75.7 � 23.8 I 4 � 1 .576 
65.6 20. 4  I 0 1 1 .684 
73.9 23.5 I 2 I 1 .728 
82.7  I 26.8 I 1 1 1 .751 
98.4  I 30.3  I 1 1 1 . 794 
72.9 I 23.2 I 3 j 1 . 809 
74.3 I 24.2 I 3 I 1 .855 
96 
N u m ber Sex Age (year) �g/dl) MCV (ft) MCH (pg) F cells (%) Hb F (%) 
-
1 99 F 26 1 1 .8  1 1 .8� 
1 32 F ad 9.9 71 .6 22.4 1 
-
1 34 - - - -F ch 1 0.7  70. 1  22.5 
--
--





-250 F 65 1 1  9 73. 8  22.9 
-- _. 
-
- -- --258 F ad. 1 0. 1  80.9  25.4  
- - -
-280 F 1 1  1 1 .9 79.8 25.8 4 
292 - -- - -- - - -F 40 1 1 . 9 72.3 
-
428 F 50 1 0 4 71 . 7  � 
-
473 F 60 1 1  80 
-- -- I  481 F 80 1 1  6 
-
-1 1  M 45 8. 7 70 
-
--
51  M 45 9.8 70.8 
-




432 M 50 1 1 . 2 74 
-
-
� 1 1 4  M 63 9.6 87.3  
71  M ... -1 5  1 0.2  77.9 
461 M 1 .08 6 .9 52. 7 
377 M 62 1 0. 1  74 
1 80 M 40 1 1 .3 
-
395 M ad. 1 0. 9  80 
446 M I 80 1 1 .7  69.3 
382 M 5 1 1 . 6  82. 1  
I- 1 62 M 2 9.6 72.3 
-
285 M 3 1 0.8  74. 1 
1 1 7  M 0.5 1 1 .3 66. 8 �28 M 62 1 0. 7  
383 M 4 1 0. 9  68. 2  
402 M 2 1 1 . 5 82 
- -
400 M 32 9 84. 8  
f- 425 M 4 1 1 . 4 68. 5 
489 M 33 8 .4  86.9 
-


























































1 09 M 
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1 8  
62 
0.25 
1 1 .9  62.2 j 
1 1 . 5 82. 4 
8.4 71 .9  
9 . 9  72. 7 
1 0. 7  
! 9. 6 72.6 





1 1 .9  
1 0. 5  
5 . 8  
1 0. 8  75. 7 
1 1 . 1 73. 7  
7.9 ! 84.8 
1 1 . 5 : 
9.4 89. 5 
8 .6 76.2 
1 1 .6 73.2 
1 0.6  91 .6 
1 0.4  57.4 
1 1  87.2 
7.4 60. 3 
- --
-
9.6 72. 6  











1 5. 9  
23 
25. 9  





21 .4  
27 
27 1 
21 .6  
26. 2  
1 8.9 
27 .4  
22. 9  











1 8. 5  
28. 4  












































--0 1 �  
-
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6 0 975 
-
-
1 01 5  1 
- - --
2 1 .094 
-
1 . 1 5i-
-
-
1 .25�_ 1 
1 307 
Number Sex 





1 8  
337 I 
23 I 
,. Note : 
ad.  : adutt 














Hb (g/dl) MCV (ft) MCH (pg) F cells (%) Hb F (%) 
1 0.7  76 1 24. 6 3 1 .368 
9.5 69 23.5 1 . 382 
1 0.7  73.6 22.8 4 1 . 746 
1 0.4  74. 1 23.8 1 1 .785 
9. 3 ! 75 I 24. 7 1 793 
1 0.8  I 84. 5  I 27 I 3 
1 0.7 I 88 I 30.2 I 4 
98 
Appendix I I I  : The general characteristics and hematological data among pregnant 
females popu lation . 
Age of 
Number Pregnancy Hb (g/d/) MCV (fI ) MCH ( pg )  F Ce l l  (%) Hb F (%) Hb A2 (%) 
(wee!sl 
20 35 1 1 .8 87 6 28.5 0.4003 2.00 
64 32 1 0  1 2.00 
3 1  40 1 3.3 0 1 2225 2.02 
1 42 32 1 2. 1  72.6 23.4 1 0 2.03 
89 36 8.2 3 2 2448 2.04 
1 6  28 1 2. 1  80 6 36.5 0.30 1 5  2.05 
27 36 1 1 7 1 0.3889 2.05 
1 1 4 1 2.9  86 29 1 2 0 2.06 
70 39 1 3.2  0 48 1 6  2.06 
1 39 28 1 1  73. 1 23.9 2 0 2.07 
63 39 1 4 6  0 0 2.07 
75 34 1 1  . 1  70.4 22.9 0.5782 2.09 
243 34 1 0.5  2 0 2 . 1 0  
1 5  40 1 1 . 7 83 26 7 1 .0926 2. 1 1  
224 34 1 1  3 0 2 . 1 1 
235 32 9.4 0 0 2. 1 1  
3 38 1 2.7 2. 1 2  
1 1 5  33 9.8 1 0 2. 1 2  
2 34 1 2.8 2. 1 2  
36 38 1 0  70 23.7 0 0.3533 2. 1 2  
32 32 1 0.6 76.9 25.3 1 1 .0659 2. 1 2  
21 9 34 1 3. 1  1 0 2. 1 4  
34 33 1 1  79 24.4 3 2. 1 7  
21 3 30 1 1 .4 2 0 2. 1 7  
244 37 1 2 . 4  0 2. 1 7  
2 1 0  36 8 . 1  66.2 20.5 2 a 2. 1 8  
1 69 29 1 0.6 73.8 24. 1 2 0 2. 1 8  
1 09 34 1 0  0 0 2. 1 8  
1 34 36 8.3 70.5 22.6 2 0 2. 1 8  
90 27 1 1 .9 1 0 .4253 2.20 
93 37 1 2.9 0 0. 1 584 2.21 
1 96 1 5  8 .2 63 1 9.3 0 2.21 
1 67 34 1 0.3 77 3 35. 1 0 0 2.22 
1 78 30 1 2.2 0 0 2.22 
1 35 36 9.8 7 1  7 23.2 1 0 2.22 
225 3 1  1 0.2 0 0 2 .24 
205 24 1 1 .7 83.5 27.7 1 0 2.24 
1 1 3  1 0.7 72.5 23.5 1 0 2.26 
234 34 9.8 0 0. 1 2.26 
242 28 1 0.3 1 0 2.28 
92 38 1 1  . 1  0 0.4088 2.28 
240 26 1 0.2 2 0.09 2.29 
30 38 1 0.7 0 0.67 1 1 2.29 
1 62 35 9 1 0.9348 2.33 
86 37 1 2  1 0.74 1 9 2.33 
1 20 29 1 0.9 8 1  7 26. 1  1 0 2.34 
1 60 32 1 0.5 0 0 2.34 
99 
Age of 
Number Preg nanc.y Hb (g/d l )  MCV (fl ) MCH (pg) F CeI !  (%) Hb F (%) Hb A2 (%) 
(week) 
1 98 27 8.8 74.3 24.2 1 0 2.34 
230 37 9.8 1 0 2.35 
230 9.8 1 2.35 
207 39 1 0 2  4 0 2.35 
1 65 36 1 0. 7  78.2 26.3 1 0 2.35 
71 35 1 1 .5 0 2.35 
38 1 2.5 0 1 .071 7 2.36 
1 91 37 1 1  3 0 2.36 
247 38 1 3.5 0 0 2.37 
1 54 28 1 1 .7 0 0 2.37 
251 36 1 1 .4 3 0 2.37 
67 38 1 3.7  0 .5382 2.37 
1 76 39 1 3.9 0 0.07 2.37 
1 64 35 1 3.5 1 0 2.38 
257 40 1 2.9 2 0 2.39 
1 5 1  1 4  1 0 2 .40 
1 1 2  32 1 1 .8 79.9 26 1 0 2 .40 
201 30 9.3 65 20.4 0 0.07 2.40 
1 77 30 1 1 .4 0 0 2.40 
1 32 26 1 3.6  90. 1  30.8 1 0 .51 44 2.41 
1 1 0  26 1 2. 1  0 0 2.41 
1 57 36 1 4.6 1 0 2.42 
1 45 36 1 2.7 86.4 29.2 1 0.91 29 2 .42 
1 52 33 1 1 .4 1 0 2.42 
246 24 1 2  2 0 2.43 
68 32 1 3.6 0 .6544 2.44 
21 4 30 1 0.5 0 0 2.44 
1 49 38 1 4 .8 1 0 6571 2.44 
202 28 1 1 .3 75 2 24.7 0 0 2.45 
1 50 26 1 2 .4 2 0 2.45 
233 37 1 2  1 0 2.46 
1 29 30 1 3  91 .2 30.5 1 0 2.46 
232 34 1 3.7  1 0 2 .46 
1 95 38 1 1 .6 90 30.7 0 0 2.47 
236 30 1 0.6 1 0 2.47 
1 30 1 0.8 81 26.6 2 0 2.47 
1 38 39 1 1 . 1 82.3 27.4 1 0 2.48 
237 39 1 3.3 2 0 2.48 
1 75 27 1 2. 1 1 0.05 2.48 
80 32 1 3. 4  0 0.6244 2.48 
88 1 2 .3 0 0 .5086 2.48 
1 84 30 1 0.5 73.7 24 1 0 2.49 
1 66 27 1 1 .7 94.8 31 .8 1 0 2.50 
66 38 1 3  1 1 .0503 2.50 
78 38 1 1 .5 2 0.33 1 8  2.50 
1 36 30 9.9 8 1 .5 27.3 1 0 .7273 2.50 
1 59 31 1 4  1 0.3629 2.50 
100 
Age of 
N u m ber  Pregnancy Hb (g/d l )  MCV (fl) MCH (pg) F CeI l  ('Yo) Hb F ('Yo) Hb A2 ('Yo) 
(week) 
227 1 1 .3 0 0 2.51 
209 34 1 1 .5 1 0 2.51 
1 0  30 1 0 5 0 0.2831 2 51 
255 1 2.2 2 0 2.52 
1 63 37 1 3.6 1 0 2.52 
1 46 28 1 1 .2 89.6 29.8 0 0.6474 2.52 
21 2 37 1 0.7 1 0 2.53 
1 3  29 1 3.7 0.4074 2.53 
1 1 1  1 2  87.6 28.7 1 0 2.54 
1 31 3 1  1 1 . 1 82.3 27.5 0 0 2.54 
239 3 1  1 3.4  3 0 2.55 
1 58 34 1 1 .2 2 0 .441 7 2.55 
74 38 1 2.3 86.4 28.8 0.81 09 2.56 
1 33 30 1 0.8 8 1 . 1  27. 1 1 1 .041 7 2.56 
8 1  28 1 3.7 1 0.4555 2.56 
1 61 36 9.6 1 0 2.56 
91 35 1 3.2 1 0 .2232 2.56 
1 47 1 0.4  71.7  25.8 0 0 2.56 
256 38 1 4.4 2 0 2.57 
1 48 38 1 2.9 0 0 2.58 
223 36 1 3.5 2 0.09 2.59 
228 31 1 2  0 0 2.60 
228 1 2  0 2.60 
204 1 1 .4 1 0 2.61 
21 1 35 1 2  1 0 2.63 
1 40 26 1 1 .2 1 02 28.7 2 0 2.63 
73 35 1 4.5 0.4865 2.64 
1 02 34 1 1 .8 0 0 2.65 
84 40 1 0.5 0 0.4589 2.65 
1 26 26 1 1 .2 94.2 3 1 .7 2 0.3 2.66 
65 36 1 1 .7 0.394 2.67 
1 94 36 1 0.5 77.1  25.6 2 0 2.68 
1 43 34 1 1 .6 82.6 27.9 0 0 2.68 
248 35 1 1  1 0 2.69 
208 28 9.6 80.2 26.5 4 0 2.70 
1 99 32 9.2 66.7 2 1 . 1  0 0 2.70 
83 8 1 0.5 0 0.4942 2.70 
1 85 29 1 1 .8 8 1 .2  27.2 0 0 2 .71 
6 28 1 1  84.2 27.6 0 0.4293 2.71 
1 72 36 1 3.9 0 0.065 2.72 
200 34 1 2  87.2 28.9 1 0.055 2.72 
1 44 36 1 1 .3 9 1 . 1  30 0 0 2.73 
222 29 1 1 . 1 1 0 2.73 
1 27 30 1 1 .4 77.5 25.3 2 0 2.74 
94 4 1 1 .3 0 0.2667 2.75 
1 89 30 1 0. 1  79.8 26.5 2 0 2.75 
26 26 1 0.9 82 29.5 3 1 . 1 991 2.76 
1 80 36 1 1  80.5 28.5 1 0 2.77 
1 0 1 
Age of 
Number Pregnancy Hb (g/dl) MCV (fl) MCH (pg) F Cell ('Yo) Hb F ('Yo) Hb A2. ('Yo) 
(week) 
226 38 1 4 2 0 0 2.77 
85 39 1 1 .9 0 0.5667 2.79 
203 1 1 . 1 77.6 25.3 1 0 2.80 
1 83 33 1 1  82 27.2 0 0 2.80 
1 97 36 1 1 .6 91 .7 30.4 0 0 2.81 
21 6 32 1 3.6 0 0 2.82 
1 82 32 9.5 84.4 27.5 1 0 2.82 
1 08 28 1 0.2 0 0 2.83 
220 24 1 3.6 0 0 2.85 
1 1 9  1 2. 1  79.6 26.3 0 0 2.86 
1 86 32 1 1 .9 0 0 2.86 
33 32 1 1 .5 86 28.5 0 2.88 
62 36 1 3 .9 0 .5579 2.88 
1 25 34 1 3.2 95.2 32.2 1 0 2.89 
79 34 1 2  1 0.4601 2.89 
21 8 38 1 1 .6 0 0.05 2.90 
1 93 34 1 2.5 1 0 2.90 
1 55 36 1 1 .4 1 0 2.90 
241 39 1 1  2 0 2.91 
99 33 9 0 0 2.93 
221 28 1 1 .7 1 0 2.93 
1 05 22 1 2.4 0 0.05 2.96 
1 21 35 1 3.2 83.8 28.5 0 0. 1 9  2.96 
1 23 23 1 1  9 8 1 .4 29.4 1 0. 1 6  2.97 
1 73 3 1  9.5 0 0 2.98 
8 35 1 3 .5 0 0.3278 2.98 
39 39 1 2.5 0 2.99 
1 07 29 1 1 .2 0 0 3.00 
50 21 1 4  1 0.6339 3.00 
1 1 6 27 1 0.3 76.5 25 1 0.05 3 .02 
82 25 1 2.5 0 0.7308 3.05 
1 90 30 1 1 .3 94 31 . 1  1 0.05 3 06 
28 36 1 2.9 0 3.06 
231 1 1 .6 0 0 .1  3.07 
44 36 1 4  0 0.4254 3.09 
53 36 1 1 .3 1 3 . 1 1 
1 56 27 1 3 .6 0 0 3 . 1 2 
54 20 9 .7  1 0.3294 3 . 1 4 
55 39 1 4. 4  2 0.9926 3. 1 4  
229 36 1 3.4  0 0 3 . 1 7 
229 1 3 .4  0 3. 1 7  
258 27 1 1  . 1  0 0 3 . 1 8 
253 30 1 5  1 3. 1 8  
252 28 1 0.3 2 0 3 . 1 9  
97 36 1 2  0 0 3.20 
52 3 1  1 2.3 1 3.22 
1 87 38 1 2.3 0 0 3.23 
41  34 1 3. 1  0 3.25 
1 02 
Age of 
N u m ber Pregnancy Hb (g/d l )  MCV (tl) MCH (pg) F CelJ (%) Hb F (%) Hb A2 (%) 
(week) 
60 34 1 0.2 0 3 31 
43 38 1 2.5 0 0 .592 3.32 
42 35 9.6 0 3.33 
58 37 1 1  5 0 3.34 
40 38 9.8 a 3.34 
57 22 1 2.7 1 3.35 
1 79 36 1 3.3 a 0.05 3.36 
1 04 38 9.5 0 a 3.38 
56 20 1 2.3 a 0.7684 3.39 
96 36 9.5 a 0.3571 3.39 
1 06 32 1 3.7 0 0 3.40 
1 03 36 1 1 3 a a 3.42 
45 29 1 2  a 3.44 
249 34 1 2.2 1 0 3.45 
1 00 30 1 4 7  a 0.05 3.46 
238 30 1 2.3 1 0 1 1  3.47 
Appendix IV ,: The genera l  characteristics and hematological data among among 
homozygotes p IVSI-5 mutation popu lation . 
Number 
F 5  1 
F 5  2 
F 6  3 
F 9  3 
F9 4 
F 1 5  3 
F 1 5  4-
F 1 5  6 
F 1 5  7 
F I 5  8 
F I 7  3 
F I 7  4 
F I 9  3 
F 1 9  4 





F21. __ 4 






1 0  
1 
-- -----


















O manL _ 
Hb (%) MCV (fI) MCH (pg) HbA2 (%) Hb F (%) 
2.8 1 3  
2 . 7  1 1 .2 
9 . 1  65 2 1 . 1  7.8 
1 88.3 28.6 2.4- 31 
1 . 1  63.8 20.3 4 . 4- 9.5 
1 0 .5 85.7 27.8 2.4 0.8 
1 1 .2 7 7 .4 25 .4- 3.3 6.4-
1 0 . 1  58.8 1 8 .1 4- . 8  
9 . 9  5 2  1 6 .3 4 . 1  
1 0  52 1 6.4 4 .5 
9.3 80.1 26.9 2.5 > 1 0  
8 . 1  1 8  25 2.5 4 .2 
9 .8 8 1 .5 21.3 2.6 24 
9.6 12.-4 22.3 5.2 
1 1 . 1 63.2 1 9 .9 5.3 0.5 
3.7 67.3 20.6 5 
9.7 68.2 22 .7  3 .6  
1 0.8 79.4 26.5 
1.6 72 . 9  25 . 1  2.6 











> 1 000 
622 
38 
1 9  
1 59 




Appendix V : The genera l  characteristics and hematological data among 
heterozygotes � IVSI-5 mutation population . 
Number IAge(years Ortgln Hb(gldl) MCWtf) MCH(pg) HbA2(�) Hb F{�) Ferrftln 
F5 3 pat(lstanl 6.1 0.5 
F5 � _pakistani �.7 
F6 1 Iranian 1 5.8 73.1 22.8 4.5 1 02  
F6 2 Iranian 1 2.3 69.9 2 1 .7 5.3 44 
F9 1 peI<lstant 1 4.2 58.7 1 8  4.5 0.5 32 
F9 2 pakistani 1 4.2 58.7 1 8.3 4.8 1 .6 32 
F 1 5  1 Baiocht 1 5.2 70.9 22 .5 4.6 7.1 
F 1 5  2 Balocht 1 2.2 61 .9 20 5 9.7 
F 1 5  5 6 Balocht 1 4.6 85.5 28.3 4.6 1 .4 4.1 
F1 7 1 Balochl 1 5.9 7.9 25 5 1 02 
F1 7 2 Balochl 1 2 .2 65.1 20.5 5 88 
F1 7 5 Balochl 1 2.5 68.3 22.4 2.2 6 
F1 7 6 Balochl 1 3.2 74.4 24.6 4.5 1 4  
F1 7 7 Ba/OCht 1 2  65.3 20.6 �.9 5 
F1 7 8 Balochl 9.9 62.9 20 2.4 1 .6 1 4  
F1 7 9 Ba/ochl 1 1 .6 62.Q 1 9.8 4.S 3 
F 1 9  1 1 2.6 64.9 20.7 5.3 1 37 
F 1 9  2 1 0.1 58.4 1 9  5.1  1 < 1  
F1 9 6 5.6 61 .7 20 5.2 4.8 23 
F 1 9  7 1 0  64.5 20 5.4 0 1 3  
F 1 9  8 6.7 n.4 27.1 3.1 0 8 
F 1 9  9 1 3. 1  65.S 21 5.3 0 1 3  
F 1 9  1 0  8.5 67.2 2 1 .6 2.1  0 
F20 1 Balochl 1 1 .2 63.9 20.9 4.8 36 
F20 2 Balochl 1 1 . 1  67 2 1 .4 7.3 9 
F20 3 Balochl 1 0.3 83.9 27.8 2.9 981 
F20 5 Balochl 6.5 56.7 1 8.7 8.2 40 
F20 6 BaJochl 9.1 71 .8 23.4 4.9 46 
F25 1 1 3.1 66.9 2 1 .4 
F25 2 1 3.8 69.1 22.1 
F25 4 1 1  66.4 20.7 
F25 5 1 1 .5 BO.4 26.3 
F25 6 1 0.3 61 .8 1 9.5 
F26 1 1 3.9 60.9 19.2 4.5 
F27 1 Omanl 1 2.8 63.2 20 4.2 
F27 2 Omanl 1 3  62.8 20.1 3.6 
F28 2 Omanl 9.9 58.1 1 7.7 4.3 4 
F29 1 UAE 1 5. 1  69 . 1  22.3 4.7 49 
F30 1 Balochl 4.8 
F33 1 Iranian 1 2  68.3 21 .6 4.3 
F38 1 64 Balochl 
F40 1 1 1 .8 64.7 1 9.4 3.7 
F42 1 1 3.2 68 21 2.3 < 2  
F43 1 50 UAE 1 3.4 73.6 22.3 4.1 292 
F43 2 35 UAE 1 1 .7 70.4 22 4.8 1 6  
